JPS61189269A - 2-(5-fluoronicotinoyl)acetic acid derivative and salt thereof - Google Patents
2-(5-fluoronicotinoyl)acetic acid derivative and salt thereofInfo
- Publication number
- JPS61189269A JPS61189269A JP60028397A JP2839785A JPS61189269A JP S61189269 A JPS61189269 A JP S61189269A JP 60028397 A JP60028397 A JP 60028397A JP 2839785 A JP2839785 A JP 2839785A JP S61189269 A JPS61189269 A JP S61189269A
- Authority
- JP
- Japan
- Prior art keywords
- salt
- general formula
- solvent
- compound represented
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000003839 salts Chemical class 0.000 title claims abstract description 89
- FWULNUQPNCDOQE-UHFFFAOYSA-N 3-(5-fluoropyridin-3-yl)-3-oxopropanoic acid Chemical class OC(=O)CC(=O)C1=CN=CC(F)=C1 FWULNUQPNCDOQE-UHFFFAOYSA-N 0.000 title claims abstract description 5
- -1 hydroxy, 3-aminopyrrolidinyl Chemical group 0.000 claims abstract description 26
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims abstract description 10
- 125000003545 alkoxy group Chemical group 0.000 claims abstract description 7
- 125000004414 alkyl thio group Chemical group 0.000 claims abstract description 5
- 125000005110 aryl thio group Chemical group 0.000 claims abstract description 5
- 229910052731 fluorine Inorganic materials 0.000 claims abstract description 4
- 125000004193 piperazinyl group Chemical group 0.000 claims abstract description 3
- 239000000126 substance Substances 0.000 claims description 13
- 125000001424 substituent group Chemical group 0.000 claims description 6
- 125000005843 halogen group Chemical group 0.000 claims description 5
- 125000003277 amino group Chemical group 0.000 claims description 4
- 125000004429 atom Chemical group 0.000 claims description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 4
- 125000001841 imino group Chemical group [H]N=* 0.000 claims description 4
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical group FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims 1
- 239000011737 fluorine Chemical group 0.000 claims 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 abstract description 89
- 239000002253 acid Substances 0.000 abstract description 17
- 230000001747 exhibiting effect Effects 0.000 abstract description 8
- 125000004494 ethyl ester group Chemical group 0.000 abstract description 5
- 241000894006 Bacteria Species 0.000 abstract description 3
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 2
- 241000192125 Firmicutes Species 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 abstract 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 113
- 239000002904 solvent Substances 0.000 description 64
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 57
- 238000006243 chemical reaction Methods 0.000 description 54
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 51
- 239000013078 crystal Substances 0.000 description 37
- 238000002844 melting Methods 0.000 description 34
- 230000008018 melting Effects 0.000 description 34
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 33
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 32
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 30
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 30
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 26
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 25
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 25
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 24
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 24
- 239000003795 chemical substances by application Substances 0.000 description 23
- 239000000243 solution Substances 0.000 description 23
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 22
- 239000000203 mixture Substances 0.000 description 19
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 18
- 239000012044 organic layer Substances 0.000 description 18
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 15
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 13
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 12
- RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 12
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 12
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 9
- 230000002411 adverse Effects 0.000 description 9
- 150000001408 amides Chemical class 0.000 description 9
- 238000000034 method Methods 0.000 description 9
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 8
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 8
- 230000000704 physical effect Effects 0.000 description 8
- 238000010992 reflux Methods 0.000 description 8
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 8
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 7
- 238000010438 heat treatment Methods 0.000 description 7
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 6
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 6
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 6
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 6
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 6
- 238000001816 cooling Methods 0.000 description 6
- 150000002170 ethers Chemical class 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 6
- 239000012046 mixed solvent Substances 0.000 description 6
- 150000003462 sulfoxides Chemical class 0.000 description 6
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 6
- RMVRSNDYEFQCLF-UHFFFAOYSA-N thiophenol Chemical compound SC1=CC=CC=C1 RMVRSNDYEFQCLF-UHFFFAOYSA-N 0.000 description 6
- 125000000217 alkyl group Chemical group 0.000 description 5
- 150000007529 inorganic bases Chemical class 0.000 description 5
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 4
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 150000001298 alcohols Chemical class 0.000 description 4
- 150000008050 dialkyl sulfates Chemical class 0.000 description 4
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethanethiol Chemical compound CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 4
- 150000008282 halocarbons Chemical class 0.000 description 4
- 230000002140 halogenating effect Effects 0.000 description 4
- 150000002576 ketones Chemical class 0.000 description 4
- YNBADRVTZLEFNH-UHFFFAOYSA-N methyl nicotinate Chemical compound COC(=O)C1=CC=CN=C1 YNBADRVTZLEFNH-UHFFFAOYSA-N 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- 150000007530 organic bases Chemical class 0.000 description 4
- 238000001953 recrystallisation Methods 0.000 description 4
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- 239000008096 xylene Substances 0.000 description 4
- GQHTUMJGOHRCHB-UHFFFAOYSA-N 2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine Chemical compound C1CCCCN2CCCN=C21 GQHTUMJGOHRCHB-UHFFFAOYSA-N 0.000 description 3
- 101150041968 CDC13 gene Proteins 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 3
- YXHKONLOYHBTNS-UHFFFAOYSA-N Diazomethane Chemical compound C=[N+]=[N-] YXHKONLOYHBTNS-UHFFFAOYSA-N 0.000 description 3
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 3
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 3
- 230000002378 acidificating effect Effects 0.000 description 3
- 150000001350 alkyl halides Chemical class 0.000 description 3
- 150000001412 amines Chemical class 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000004440 column chromatography Methods 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- 239000012156 elution solvent Substances 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 239000000543 intermediate Substances 0.000 description 3
- 229910052740 iodine Inorganic materials 0.000 description 3
- 239000010410 layer Substances 0.000 description 3
- 150000004702 methyl esters Chemical class 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 3
- 229920006395 saturated elastomer Polymers 0.000 description 3
- 239000000741 silica gel Substances 0.000 description 3
- 229910002027 silica gel Inorganic materials 0.000 description 3
- PMBXCGGQNSVESQ-UHFFFAOYSA-N 1-Hexanethiol Chemical compound CCCCCCS PMBXCGGQNSVESQ-UHFFFAOYSA-N 0.000 description 2
- PAMIQIKDUOTOBW-UHFFFAOYSA-N 1-methylpiperidine Chemical compound CN1CCCCC1 PAMIQIKDUOTOBW-UHFFFAOYSA-N 0.000 description 2
- OISVCGZHLKNMSJ-UHFFFAOYSA-N 2,6-dimethylpyridine Chemical compound CC1=CC=CC(C)=N1 OISVCGZHLKNMSJ-UHFFFAOYSA-N 0.000 description 2
- BDFAOUQQXJIZDG-UHFFFAOYSA-N 2-methylpropane-1-thiol Chemical compound CC(C)CS BDFAOUQQXJIZDG-UHFFFAOYSA-N 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- LSDPWZHWYPCBBB-UHFFFAOYSA-N Methanethiol Chemical compound SC LSDPWZHWYPCBBB-UHFFFAOYSA-N 0.000 description 2
- HGINADPHJQTSKN-UHFFFAOYSA-N Monoethyl malonic acid Chemical compound CCOC(=O)CC(O)=O HGINADPHJQTSKN-UHFFFAOYSA-N 0.000 description 2
- JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 150000008065 acid anhydrides Chemical class 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- 150000001340 alkali metals Chemical class 0.000 description 2
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 2
- 150000001342 alkaline earth metals Chemical class 0.000 description 2
- 230000029936 alkylation Effects 0.000 description 2
- 238000005804 alkylation reaction Methods 0.000 description 2
- GZUXJHMPEANEGY-UHFFFAOYSA-N bromomethane Chemical compound BrC GZUXJHMPEANEGY-UHFFFAOYSA-N 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 2
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 2
- 238000002512 chemotherapy Methods 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 125000001309 chloro group Chemical group Cl* 0.000 description 2
- 101150084411 crn1 gene Proteins 0.000 description 2
- 239000002178 crystalline material Substances 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- RYPWQHONZWFXBN-UHFFFAOYSA-N dichloromethyl(methylidene)-$l^{3}-chlorane Chemical compound ClC(Cl)Cl=C RYPWQHONZWFXBN-UHFFFAOYSA-N 0.000 description 2
- 235000013601 eggs Nutrition 0.000 description 2
- DTDJTYROZSFKKY-UHFFFAOYSA-N ethyl 3-[2-(2,4-difluoroanilino)-5-fluoro-6-oxo-1h-pyridin-3-yl]-3-oxopropanoate Chemical compound CCOC(=O)CC(=O)C1=CC(F)=C(O)N=C1NC1=CC=C(F)C=C1F DTDJTYROZSFKKY-UHFFFAOYSA-N 0.000 description 2
- UJQJRGPXXBGMME-UHFFFAOYSA-N ethyl 3-[6-(3-aminopyrrolidin-1-yl)-2-(2,4-difluoroanilino)-5-fluoropyridin-3-yl]-3-oxopropanoate Chemical compound CCOC(=O)CC(=O)C1=CC(F)=C(N2CC(N)CC2)N=C1NC1=CC=C(F)C=C1F UJQJRGPXXBGMME-UHFFFAOYSA-N 0.000 description 2
- NBQCWDAQXYFUFG-UHFFFAOYSA-N ethyl 3-[6-chloro-2-(2,4-difluoroanilino)-5-fluoropyridin-3-yl]-3-oxopropanoate Chemical compound CCOC(=O)CC(=O)C1=CC(F)=C(Cl)N=C1NC1=CC=C(F)C=C1F NBQCWDAQXYFUFG-UHFFFAOYSA-N 0.000 description 2
- 125000001153 fluoro group Chemical group F* 0.000 description 2
- 238000005187 foaming Methods 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 159000000003 magnesium salts Chemical class 0.000 description 2
- NIQQIJXGUZVEBB-UHFFFAOYSA-N methanol;propan-2-one Chemical compound OC.CC(C)=O NIQQIJXGUZVEBB-UHFFFAOYSA-N 0.000 description 2
- OCDVMYOLEVTDBO-UHFFFAOYSA-N methyl 2-(2,4-difluoroanilino)-5-fluoro-6-oxo-1h-pyridine-3-carboxylate Chemical compound COC(=O)C1=CC(F)=C(O)N=C1NC1=CC=C(F)C=C1F OCDVMYOLEVTDBO-UHFFFAOYSA-N 0.000 description 2
- VWAMZARUIDDXJJ-UHFFFAOYSA-N methyl 3-amino-3-iminopropanoate;hydrochloride Chemical compound Cl.COC(=O)CC(N)=N VWAMZARUIDDXJJ-UHFFFAOYSA-N 0.000 description 2
- DDOUYBIFSQQMFY-UHFFFAOYSA-N methyl 6-(3-acetamidopyrrolidin-1-yl)-2-(2,4-difluoroanilino)-5-fluoropyridine-3-carboxylate Chemical compound COC(=O)C1=CC(F)=C(N2CC(CC2)NC(C)=O)N=C1NC1=CC=C(F)C=C1F DDOUYBIFSQQMFY-UHFFFAOYSA-N 0.000 description 2
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 150000002825 nitriles Chemical class 0.000 description 2
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 2
- 229960005235 piperonyl butoxide Drugs 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 239000012312 sodium hydride Substances 0.000 description 2
- 229910000104 sodium hydride Inorganic materials 0.000 description 2
- 150000003573 thiols Chemical class 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- VPAHTUQECJIGCK-UHFFFAOYSA-N (2-methylphenyl)sulfonyl 2-methylbenzenesulfonate Chemical compound CC1=CC=CC=C1S(=O)(=O)OS(=O)(=O)C1=CC=CC=C1C VPAHTUQECJIGCK-UHFFFAOYSA-N 0.000 description 1
- OGFAWKRXZLGJSK-UHFFFAOYSA-N 1-(2,4-dihydroxyphenyl)-2-(4-nitrophenyl)ethanone Chemical compound OC1=CC(O)=CC=C1C(=O)CC1=CC=C([N+]([O-])=O)C=C1 OGFAWKRXZLGJSK-UHFFFAOYSA-N 0.000 description 1
- ZRKMQKLGEQPLNS-UHFFFAOYSA-N 1-Pentanethiol Chemical compound CCCCCS ZRKMQKLGEQPLNS-UHFFFAOYSA-N 0.000 description 1
- RRQYJINTUHWNHW-UHFFFAOYSA-N 1-ethoxy-2-(2-ethoxyethoxy)ethane Chemical compound CCOCCOCCOCC RRQYJINTUHWNHW-UHFFFAOYSA-N 0.000 description 1
- PVJZBZSCGJAWNG-UHFFFAOYSA-N 2,4,6-trimethylbenzenesulfonyl chloride Chemical compound CC1=CC(C)=C(S(Cl)(=O)=O)C(C)=C1 PVJZBZSCGJAWNG-UHFFFAOYSA-N 0.000 description 1
- CEPCPXLLFXPZGW-UHFFFAOYSA-N 2,4-difluoroaniline Chemical compound NC1=CC=C(F)C=C1F CEPCPXLLFXPZGW-UHFFFAOYSA-N 0.000 description 1
- 125000004215 2,4-difluorophenyl group Chemical group [H]C1=C([H])C(*)=C(F)C([H])=C1F 0.000 description 1
- HQXZJEJWQGGLLZ-UHFFFAOYSA-N 2-(2,4-difluoroanilino)-5-fluoro-6-oxo-1h-pyridine-3-carboxylic acid Chemical compound OC(=O)C1=CC(F)=C(O)N=C1NC1=CC=C(F)C=C1F HQXZJEJWQGGLLZ-UHFFFAOYSA-N 0.000 description 1
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 1
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
- WAXXMBOGFVJIHX-UHFFFAOYSA-N 2-hydroxybutan-2-yl acetate Chemical compound CCC(C)(O)OC(C)=O WAXXMBOGFVJIHX-UHFFFAOYSA-N 0.000 description 1
- HDECRAPHCDXMIJ-UHFFFAOYSA-N 2-methylbenzenesulfonyl chloride Chemical compound CC1=CC=CC=C1S(Cl)(=O)=O HDECRAPHCDXMIJ-UHFFFAOYSA-N 0.000 description 1
- WFBUQJSXXDVYFZ-UHFFFAOYSA-N 2-methylpropane-2-sulfonyl chloride Chemical compound CC(C)(C)S(Cl)(=O)=O WFBUQJSXXDVYFZ-UHFFFAOYSA-N 0.000 description 1
- WPHUUIODWRNJLO-UHFFFAOYSA-N 2-nitrobenzenesulfonyl chloride Chemical compound [O-][N+](=O)C1=CC=CC=C1S(Cl)(=O)=O WPHUUIODWRNJLO-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- UJHBRXADHIQCLJ-UHFFFAOYSA-N 3-oxo-3-pyridin-3-ylpropanoic acid Chemical compound OC(=O)CC(=O)C1=CC=CN=C1 UJHBRXADHIQCLJ-UHFFFAOYSA-N 0.000 description 1
- QXUSBOKZKRAPTI-UHFFFAOYSA-N 3h-1,8-naphthyridin-4-one Chemical class C1=CC=C2C(=O)CC=NC2=N1 QXUSBOKZKRAPTI-UHFFFAOYSA-N 0.000 description 1
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 1
- 241001120493 Arene Species 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- ZFAGXQVYYWOLNK-UHFFFAOYSA-N CCO[Mg] Chemical compound CCO[Mg] ZFAGXQVYYWOLNK-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- BWLUMTFWVZZZND-UHFFFAOYSA-N Dibenzylamine Chemical compound C=1C=CC=CC=1CNCC1=CC=CC=C1 BWLUMTFWVZZZND-UHFFFAOYSA-N 0.000 description 1
- XBPCUCUWBYBCDP-UHFFFAOYSA-N Dicyclohexylamine Chemical compound C1CCCCC1NC1CCCCC1 XBPCUCUWBYBCDP-UHFFFAOYSA-N 0.000 description 1
- VPIAKHNXCOTPAY-UHFFFAOYSA-N Heptane-1-thiol Chemical compound CCCCCCCS VPIAKHNXCOTPAY-UHFFFAOYSA-N 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 239000012359 Methanesulfonyl chloride Substances 0.000 description 1
- ZSXGLVDWWRXATF-UHFFFAOYSA-N N,N-dimethylformamide dimethyl acetal Chemical compound COC(OC)N(C)C ZSXGLVDWWRXATF-UHFFFAOYSA-N 0.000 description 1
- 241001474791 Proboscis Species 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 150000001242 acetic acid derivatives Chemical class 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910001854 alkali hydroxide Inorganic materials 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 125000004390 alkyl sulfonyl group Chemical group 0.000 description 1
- 239000002168 alkylating agent Substances 0.000 description 1
- 229940100198 alkylating agent Drugs 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- HOPRXXXSABQWAV-UHFFFAOYSA-N anhydrous collidine Natural products CC1=CC=NC(C)=C1C HOPRXXXSABQWAV-UHFFFAOYSA-N 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- SLUNEGLMXGHOLY-UHFFFAOYSA-N benzene;hexane Chemical compound CCCCCC.C1=CC=CC=C1 SLUNEGLMXGHOLY-UHFFFAOYSA-N 0.000 description 1
- MLWPJXZKQOPTKZ-UHFFFAOYSA-N benzenesulfonyl benzenesulfonate Chemical compound C=1C=CC=CC=1S(=O)(=O)OS(=O)(=O)C1=CC=CC=C1 MLWPJXZKQOPTKZ-UHFFFAOYSA-N 0.000 description 1
- CSKNSYBAZOQPLR-UHFFFAOYSA-N benzenesulfonyl chloride Chemical compound ClS(=O)(=O)C1=CC=CC=C1 CSKNSYBAZOQPLR-UHFFFAOYSA-N 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- RDHPKYGYEGBMSE-UHFFFAOYSA-N bromoethane Chemical compound CCBr RDHPKYGYEGBMSE-UHFFFAOYSA-N 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- UTBIMNXEDGNJFE-UHFFFAOYSA-N collidine Natural products CC1=CC=C(C)C(C)=N1 UTBIMNXEDGNJFE-UHFFFAOYSA-N 0.000 description 1
- 229940125782 compound 2 Drugs 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- WLXALCKAKGDNAT-UHFFFAOYSA-N diazoethane Chemical compound CC=[N+]=[N-] WLXALCKAKGDNAT-UHFFFAOYSA-N 0.000 description 1
- 125000004177 diethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- DENRZWYUOJLTMF-UHFFFAOYSA-N diethyl sulfate Chemical compound CCOS(=O)(=O)OCC DENRZWYUOJLTMF-UHFFFAOYSA-N 0.000 description 1
- 229940008406 diethyl sulfate Drugs 0.000 description 1
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
- 229940019778 diethylene glycol diethyl ether Drugs 0.000 description 1
- 125000004212 difluorophenyl group Chemical group 0.000 description 1
- SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 description 1
- KZNICNPSHKQLFF-UHFFFAOYSA-N dihydromaleimide Natural products O=C1CCC(=O)N1 KZNICNPSHKQLFF-UHFFFAOYSA-N 0.000 description 1
- VAYGXNSJCAHWJZ-UHFFFAOYSA-N dimethyl sulfate Chemical compound COS(=O)(=O)OC VAYGXNSJCAHWJZ-UHFFFAOYSA-N 0.000 description 1
- HPYNZHMRTTWQTB-UHFFFAOYSA-N dimethylpyridine Natural products CC1=CC=CN=C1C HPYNZHMRTTWQTB-UHFFFAOYSA-N 0.000 description 1
- WNAHIZMDSQCWRP-UHFFFAOYSA-N dodecane-1-thiol Chemical compound CCCCCCCCCCCCS WNAHIZMDSQCWRP-UHFFFAOYSA-N 0.000 description 1
- FRYHCSODNHYDPU-UHFFFAOYSA-N ethanesulfonyl chloride Chemical compound CCS(Cl)(=O)=O FRYHCSODNHYDPU-UHFFFAOYSA-N 0.000 description 1
- 150000002168 ethanoic acid esters Chemical class 0.000 description 1
- VCYZVXRKYPKDQB-UHFFFAOYSA-N ethyl 2-fluoroacetate Chemical compound CCOC(=O)CF VCYZVXRKYPKDQB-UHFFFAOYSA-N 0.000 description 1
- JAOZYEBZYMSWOL-UHFFFAOYSA-N ethyl 3-[2-(2,4-difluoroanilino)-6-ethylsulfanyl-5-fluoropyridin-3-yl]-3-oxopropanoate Chemical compound CCOC(=O)CC(=O)C1=CC(F)=C(SCC)N=C1NC1=CC=C(F)C=C1F JAOZYEBZYMSWOL-UHFFFAOYSA-N 0.000 description 1
- UANRJKODPIQWKQ-UHFFFAOYSA-N ethyl 3-[6-(3-acetamidopyrrolidin-1-yl)-2-(2,4-difluoroanilino)-5-fluoropyridin-3-yl]-3-oxopropanoate Chemical compound CCOC(=O)CC(=O)C1=CC(F)=C(N2CC(CC2)NC(C)=O)N=C1NC1=CC=C(F)C=C1F UANRJKODPIQWKQ-UHFFFAOYSA-N 0.000 description 1
- HSDKTLKBDJXJQU-UHFFFAOYSA-N ethyl 3-amino-3-iminopropanoate Chemical compound CCOC(=O)CC(N)=N HSDKTLKBDJXJQU-UHFFFAOYSA-N 0.000 description 1
- APQGYFNHIWMRIJ-UHFFFAOYSA-N ethyl 3-oxo-3-pyridin-3-ylpropanoate Chemical compound CCOC(=O)CC(=O)C1=CC=CN=C1 APQGYFNHIWMRIJ-UHFFFAOYSA-N 0.000 description 1
- KVDWVVFKJXRGLQ-UHFFFAOYSA-N ethyl 7-(3-acetamidopyrrolidin-1-yl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylate Chemical compound C12=NC(N3CC(CC3)NC(C)=O)=C(F)C=C2C(=O)C(C(=O)OCC)=CN1C1=CC=C(F)C=C1F KVDWVVFKJXRGLQ-UHFFFAOYSA-N 0.000 description 1
- OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical compound CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 description 1
- 125000001207 fluorophenyl group Chemical group 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
- 230000026030 halogenation Effects 0.000 description 1
- 238000005658 halogenation reaction Methods 0.000 description 1
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- UEGPKNKPLBYCNK-UHFFFAOYSA-L magnesium acetate Chemical compound [Mg+2].CC([O-])=O.CC([O-])=O UEGPKNKPLBYCNK-UHFFFAOYSA-L 0.000 description 1
- 239000011654 magnesium acetate Substances 0.000 description 1
- 235000011285 magnesium acetate Nutrition 0.000 description 1
- 229940069446 magnesium acetate Drugs 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- IZDROVVXIHRYMH-UHFFFAOYSA-N methanesulfonic anhydride Chemical compound CS(=O)(=O)OS(C)(=O)=O IZDROVVXIHRYMH-UHFFFAOYSA-N 0.000 description 1
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 1
- LGOWYAHPWSCHQV-UHFFFAOYSA-N methyl 2-(2,4-difluoroanilino)-6-ethylsulfanyl-5-fluoropyridine-3-carboxylate Chemical compound C1=C(F)C(SCC)=NC(NC=2C(=CC(F)=CC=2)F)=C1C(=O)OC LGOWYAHPWSCHQV-UHFFFAOYSA-N 0.000 description 1
- 229940102396 methyl bromide Drugs 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- XONPDZSGENTBNJ-UHFFFAOYSA-N molecular hydrogen;sodium Chemical compound [Na].[H][H] XONPDZSGENTBNJ-UHFFFAOYSA-N 0.000 description 1
- CQDGTJPVBWZJAZ-UHFFFAOYSA-N monoethyl carbonate Chemical compound CCOC(O)=O CQDGTJPVBWZJAZ-UHFFFAOYSA-N 0.000 description 1
- ACTNHJDHMQSOGL-UHFFFAOYSA-N n',n'-dibenzylethane-1,2-diamine Chemical compound C=1C=CC=CC=1CN(CCN)CC1=CC=CC=C1 ACTNHJDHMQSOGL-UHFFFAOYSA-N 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- PSZYNBSKGUBXEH-UHFFFAOYSA-N naphthalene-1-sulfonic acid Chemical compound C1=CC=C2C(S(=O)(=O)O)=CC=CC2=C1 PSZYNBSKGUBXEH-UHFFFAOYSA-N 0.000 description 1
- DASJFYAPNPUBGG-UHFFFAOYSA-N naphthalene-1-sulfonyl chloride Chemical compound C1=CC=C2C(S(=O)(=O)Cl)=CC=CC2=C1 DASJFYAPNPUBGG-UHFFFAOYSA-N 0.000 description 1
- SEXOVMIIVBKGGM-UHFFFAOYSA-N naphthalene-1-thiol Chemical compound C1=CC=C2C(S)=CC=CC2=C1 SEXOVMIIVBKGGM-UHFFFAOYSA-N 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- KZCOBXFFBQJQHH-UHFFFAOYSA-N octane-1-thiol Chemical compound CCCCCCCCS KZCOBXFFBQJQHH-UHFFFAOYSA-N 0.000 description 1
- 125000005447 octyloxy group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])O* 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- UXCDUFKZSUBXGM-UHFFFAOYSA-N phosphoric tribromide Chemical compound BrP(Br)(Br)=O UXCDUFKZSUBXGM-UHFFFAOYSA-N 0.000 description 1
- UHZYTMXLRWXGPK-UHFFFAOYSA-N phosphorus pentachloride Chemical compound ClP(Cl)(Cl)(Cl)Cl UHZYTMXLRWXGPK-UHFFFAOYSA-N 0.000 description 1
- FAIAAWCVCHQXDN-UHFFFAOYSA-N phosphorus trichloride Chemical compound ClP(Cl)Cl FAIAAWCVCHQXDN-UHFFFAOYSA-N 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- RPDAUEIUDPHABB-UHFFFAOYSA-N potassium ethoxide Chemical compound [K+].CC[O-] RPDAUEIUDPHABB-UHFFFAOYSA-N 0.000 description 1
- BDAWXSQJJCIFIK-UHFFFAOYSA-N potassium methoxide Chemical compound [K+].[O-]C BDAWXSQJJCIFIK-UHFFFAOYSA-N 0.000 description 1
- SUVIGLJNEAMWEG-UHFFFAOYSA-N propane-1-thiol Chemical compound CCCS SUVIGLJNEAMWEG-UHFFFAOYSA-N 0.000 description 1
- DRINJBFRTLBHNF-UHFFFAOYSA-N propane-2-sulfonyl chloride Chemical compound CC(C)S(Cl)(=O)=O DRINJBFRTLBHNF-UHFFFAOYSA-N 0.000 description 1
- 125000006239 protecting group Chemical group 0.000 description 1
- SBMSLRMNBSMKQC-UHFFFAOYSA-N pyrrolidin-1-amine Chemical compound NN1CCCC1 SBMSLRMNBSMKQC-UHFFFAOYSA-N 0.000 description 1
- NJPNCMOUEXEGBL-UHFFFAOYSA-N pyrrolidin-1-ium-3-ylazanium;dichloride Chemical compound Cl.Cl.NC1CCNC1 NJPNCMOUEXEGBL-UHFFFAOYSA-N 0.000 description 1
- NGXSWUFDCSEIOO-UHFFFAOYSA-N pyrrolidin-3-amine Chemical compound NC1CCNC1 NGXSWUFDCSEIOO-UHFFFAOYSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 229960002317 succinimide Drugs 0.000 description 1
- 150000003460 sulfonic acids Chemical class 0.000 description 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 1
- 230000006103 sulfonylation Effects 0.000 description 1
- 238000005694 sulfonylation reaction Methods 0.000 description 1
- YBBRCQOCSYXUOC-UHFFFAOYSA-N sulfuryl dichloride Chemical compound ClS(Cl)(=O)=O YBBRCQOCSYXUOC-UHFFFAOYSA-N 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- GFYHSKONPJXCDE-UHFFFAOYSA-N sym-collidine Natural products CC1=CN=C(C)C(C)=C1 GFYHSKONPJXCDE-UHFFFAOYSA-N 0.000 description 1
- 238000006177 thiolation reaction Methods 0.000 description 1
- IMFACGCPASFAPR-UHFFFAOYSA-N tributylamine Chemical compound CCCCN(CCCC)CCCC IMFACGCPASFAPR-UHFFFAOYSA-N 0.000 description 1
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Abstract
Description
【発明の詳細な説明】
〔産業上の利用分野〕
本発明はグラム陽性菌2よびグラム陰性菌に対して強力
な抗菌作用を示す、一般式
で表わされる1−アリール−1,4−ジヒドロ−4−オ
キソナフチリジン誘導体およびその塩の重要な中間体で
ある一般式
で表わされる2−(5−フルオロニコチノイル)酢酸誘
導体およびその塩に関する。Detailed Description of the Invention [Industrial Field of Application] The present invention provides 1-aryl-1,4-dihydro- The present invention relates to 2-(5-fluoronicotinoyl)acetic acid derivatives represented by the general formula and salts thereof, which are important intermediates for 4-oxonaphthyridine derivatives and salts thereof.
一般式(I)で表わされる1−アリール−1,4−ジヒ
ドロ−4−オキソナフチリジン誘導体およびそのmu、
第24回インターサイエンス・コンフエランス・オン・
アンチミクロノくイアル・エージェンツ0アンド・ケモ
セラピ−(InterscienceConferen
ce on Anttmicrobial Agent
s andChemotherapy )要旨集第10
2〜104頁および特願昭59−84963号において
、ダラム陽性菌およびダラム陰性菌に対して強い抗菌力
を示し、経口または非経口投与によ)高い血中濃度を得
ることができ、かつ安全性が高いなどの優れた性質を有
することが示されている。しかしこれらの化合物を製造
する方法として、一般式(n)で表わされる2−(5−
フルオロニコチノイル)酢酸誘導体マたはその塩を経由
する方法は全く知られていない。1-aryl-1,4-dihydro-4-oxonaphthyridine derivatives represented by general formula (I) and their mu,
24th Interscience Conference on
Antimicrobial Agents and Chemotherapy (Interscience Conference
ce on Anttmicrobial Agent
s and Chemotherapy) Abstracts No. 10
In pages 2 to 104 and Japanese Patent Application No. 59-84963, it is shown that it has strong antibacterial activity against Durum-positive bacteria and Durum-negative bacteria, can obtain high blood concentrations by oral or parenteral administration, and is safe. It has been shown to have excellent properties such as high durability. However, as a method for producing these compounds, 2-(5-
There is no known method using fluoronicotinoyl) acetic acid derivatives or their salts.
本発明の目的は、一般式(I)で表わされる1−アリー
ル−1,4−ジヒドロ−4−オキソナフチリジン誘導体
およびその塩を製造する際の有用な新規中間体を提供す
ることにある。 ゛〔問題点を解決するための手段〕
かかる状況下に2いて、本発明者らは鋭意研究した結果
、一般式(II)で表わされる2−(5−フルオロニコ
チノイル)酢酸誘導体およびその塩が、中間体として有
用であることを見出し、本発明を完成子るに至った。An object of the present invention is to provide a novel intermediate useful in producing 1-aryl-1,4-dihydro-4-oxonaphthyridine derivatives represented by general formula (I) and salts thereof. [Means for Solving the Problems] Under such circumstances, the present inventors have conducted extensive research and have developed a 2-(5-fluoronicotinoyl)acetic acid derivative represented by general formula (II) and its salts. was found to be useful as an intermediate, leading to the completion of the present invention.
以下1本発明の詳細な説明する。The present invention will be explained in detail below.
本明細書中でR1およびR111L で示されるカルボ
キシル保護形成基としては通常当該分野で使用されるも
の、たとえば、アルキル基、ベンジル基、ピバロイルオ
キシメチル基、トリメチルシリル基などおよび特開昭5
9−80665号公報などに記載された通常のカルボキ
シル基の保護基が挙げられる。In this specification, the carboxyl protection-forming groups represented by R1 and R111L include those commonly used in the art, such as alkyl groups, benzyl groups, pivaloyloxymethyl groups, trimethylsilyl groups, and JP-A No. 5
Examples include the usual carboxyl group-protecting groups described in Japanese Patent No. 9-80665 and the like.
R2におけるハロゲン原子としては、たとえば、フッ素
原子、塩素原子、臭累原子、ヨウ素原子;アルコキシ基
としては、たとえば、メトキシ、エトキシ、n−プロポ
キシ、イソブトキシ、ペンチルオキシ、ヘキシルオキシ
、ヘプチルオキシ、オクチルオキシ、ドデシルオキシな
ど;アルキルチオ基としては、たとえば、メチルチオ、
エチルチオ、n−プロピルチオ、イソブチルチオ、ペン
チルチオ、ヘキシルチオ、ヘプチルチオ、オクチルチオ
、ドデシルチオなど;アリールチオ基としては、元とえ
ば、フェニルチオ、ナフチルチオなど;アルカンスルホ
ニルオキシ基としては、たとえば、メタンスルホニルオ
キシ、エタンスルホニルオキシ、1−71チルエタンス
ルホニルオキシ、1.l−ジメチルエタンスルホニルオ
キシなト;アレーンスルホニルオキシ基としては、たと
えハ、ヘンセンスルホニルオキシ、ナフタレンスルホニ
ルオキシなどの基が挙げられる。Examples of the halogen atom in R2 include fluorine atom, chlorine atom, odor atom, and iodine atom; examples of alkoxy groups include methoxy, ethoxy, n-propoxy, isobutoxy, pentyloxy, hexyloxy, heptyloxy, and octyloxy. , dodecyloxy, etc.; examples of the alkylthio group include methylthio,
Ethylthio, n-propylthio, isobutylthio, pentylthio, hexylthio, heptylthio, octylthio, dodecylthio, etc.; Arylthio groups include phenylthio, naphthylthio, etc.; alkanesulfonyloxy groups include methanesulfonyloxy, ethanesulfonyloxy , 1-71 thylethanesulfonyloxy, 1. Examples of the arenesulfonyloxy group include l-dimethylethanesulfonyloxy, hensensulfonyloxy, and naphthalenesulfonyloxy.
上記したうち、アルコキシ、アルキルチオ、アリールチ
オ、アルカンスルホニルオキシおよびアレーンスルホニ
ルオキシ基は置換基を有していてもよく、これらの置換
基としては、たとえば、フッ素原子、塩素原子、臭累原
子、ヨウ素原子などのハロゲン原子;ニトロ基;メチル
、エチル、n−プロピル、イソプロピル、n−ブチル、
イソブチル、see、−ブチル、tert 、−ブチル
などのアルキル基;メトキシ、エトキシ、n−プロポキ
シ、イソプロポキシ、n−ブトキシ、イソブトキシ、8
ee、−ブトキシ、 tert、−ブトキシなどのアル
コキシ基などが挙げられる。Among the above, alkoxy, alkylthio, arylthio, alkanesulfonyloxy, and arenesulfonyloxy groups may have a substituent, and examples of these substituents include fluorine atom, chlorine atom, odor atom, and iodine atom. Halogen atoms such as; nitro group; methyl, ethyl, n-propyl, isopropyl, n-butyl,
Alkyl groups such as isobutyl, see, -butyl, tert, -butyl; methoxy, ethoxy, n-propoxy, isopropoxy, n-butoxy, isobutoxy, 8
Examples include alkoxy groups such as ee, -butoxy, tert, and -butoxy.
tた、R2およヒR3におけるアミノ基が保饅されてい
てもよい3−アミノピロリジニル基およびイミノ基が保
護されていてもよいピペラジニル基におけるアミノ基お
よびイミノ基の保護基としては、通常当該分野で使用さ
れるもの、たとえば、ホルミル、アセチルなどのアシル
基などが挙げられる。In addition, as protecting groups for the amino group and imino group in the 3-aminopyrrolidinyl group in which the amino group in R2 and R3 may be preserved and the piperazinyl group in which the imino group may be protected, Those commonly used in the field include, for example, acyl groups such as formyl and acetyl.
また、一般式(I)および(II)で表わされる化合物
の塩としては、通常知られているアミノ基、イミノ基な
どの塩基性第1たはカルボキシル基、ヒドロキシル基な
どの酸性基における塩が挙げられる。In addition, as salts of the compounds represented by general formulas (I) and (II), commonly known salts of basic primary groups such as amino groups and imino groups or acidic groups such as carboxyl groups and hydroxyl groups are used. Can be mentioned.
塩基性基における塩としては、たとえば、塩酸、臭化水
素酸、硫酸などの鉱酸との地;シュウ酸。Examples of salts with basic groups include salts with mineral acids such as hydrochloric acid, hydrobromic acid, and sulfuric acid; oxalic acid.
クエン酸、トリフルオロ酢酸などの有機カルボン酸との
塩;メクンスルホン酸、p−トルエンスルホン酸、ナフ
タレンスルホン酸などのスルホン酸との塩を、酸性基に
おける塩としては、たとえば、ナトリウム、カリウムな
どのアルカリ金属との塩;カルシウム、マグネシウムな
どのアルカリ土類金属との塩;アンモニウム塩;ブロカ
イン、ジベンジルアミン、N、N−ジベンジルエチレン
ジアミン、トリエチルアミン、ピリジン、N、N−ジメ
チルアニリン、N−メチルピペリジン、ジエチルアミン
、ジシクロヘキシルアミンなどの含窒素有機塩基との塩
を挙げることができる。Salts with organic carboxylic acids such as citric acid and trifluoroacetic acid; salts with sulfonic acids such as mecnesulfonic acid, p-toluenesulfonic acid and naphthalenesulfonic acid; salts with acidic groups include, for example, sodium, potassium, etc. Salts with alkali metals; salts with alkaline earth metals such as calcium and magnesium; ammonium salts; brocaine, dibenzylamine, N,N-dibenzylethylenediamine, triethylamine, pyridine, N,N-dimethylaniline, N-methyl Salts with nitrogen-containing organic bases such as piperidine, diethylamine, and dicyclohexylamine can be mentioned.
つぎに、本発明化合物の製造法について詳説する。Next, the method for producing the compound of the present invention will be explained in detail.
一般式(■)で表わされる化合物またはその塩は、たと
えば、つぎの製造ルートに従って製造することができる
。The compound represented by the general formula (■) or a salt thereof can be produced, for example, according to the following production route.
C以下余白)
r゛
(II)またはその塩
= 8 =
一般式(III)で表わされる化合物のカルボキシル基
における反応性誘導体としては、たとえば、酸クロリド
、酸プロミドなどの酸へロゲニド;酸無水物;炭酸モノ
エチルエステルなどとの混合酸無水物;ジニトロフェニ
ルエステル、シアノメチルエステル、スクシンイミドエ
ステルなどの活性エステル;イミダゾールなどとの活性
酸アミドなどが挙げられる。(Blank below C) r゛(II) or its salt = 8 = Reactive derivatives at the carboxyl group of the compound represented by the general formula (III) include, for example, acid herogenides such as acid chloride and acid bromide; acid anhydrides; ; Mixed acid anhydrides with carbonic acid monoethyl ester, etc.; Active esters, such as dinitrophenyl ester, cyanomethyl ester, succinimide ester; Active acid amides, with imidazole, etc.;
また、一般式(IV)および(V)で表わされる化合物
の塩としては、たとえば、リチウム、カリウム、ナトリ
ウムなどのアルカリ金属との塩:マグネシウムなどのア
ルカリ土類金属との塩;エトキシマグネシウムとの塩な
どが挙げられる。Salts of the compounds represented by formulas (IV) and (V) include, for example, salts with alkali metals such as lithium, potassium, and sodium; salts with alkaline earth metals such as magnesium; and salts with ethoxymagnesium. Examples include salt.
また、一般式(VI)で表わされる化合物の塩としては
、一般式(I)および(n)で表わされる化合物の塩で
説明したと同様の塩が挙げられる。Further, examples of the salt of the compound represented by the general formula (VI) include the same salts as explained for the salts of the compound represented by the general formulas (I) and (n).
一般式(III)または(VI)で表わされる化合物も
しくはそれらの塩は通常適当な溶媒中、一般式(III
)で表わされる化合物のカルボキシル基における反応性
誘導体に、それぞれ一般式(V) tたは(IV)で反
応に悪影響を与えないものであれば特に限定されないが
、具体的には、水;メタノール、エタノール、2−7”
ロバノールなどのアルコール類;ベンゼン、トルエンな
どの芳香族炭化水素類;塩什メチレン、クロロホルム、
ジクロロエタンなどのハロケン化炭化水素類;ジエチル
エーテル、テ)ラヒドロフラン、ジオキサンなどのエー
テル類;アセトニトリルなどのニトリル類iN、N−ジ
メチルホルムアミド、N、N−ジメチルアセトアミドな
どのアミド類などが挙げられる。また、一般イヒ金物の
カルボキシル基における反応性誘導体に対して等モル以
上、好ましくは1.0〜2.5倍モルである。本反応は
通常−50〜100℃、好ましくは一20〜70°Cで
、5分〜30時間実施すればよい。The compound represented by the general formula (III) or (VI) or a salt thereof is usually prepared in a suitable solvent.
) The reactive derivative at the carboxyl group of the compound represented by formula (V) or (IV) is not particularly limited as long as it does not adversely affect the reaction, but specifically, water; methanol can be used. , ethanol, 2-7”
Alcohols such as lovanol; Aromatic hydrocarbons such as benzene and toluene; Salt, methylene, chloroform,
Examples include halokenated hydrocarbons such as dichloroethane; ethers such as diethyl ether, te)rahydrofuran, and dioxane; nitriles such as acetonitrile; amides such as iN, N-dimethylformamide, and N,N-dimethylacetamide; and the like. Further, the amount is equal to or more, preferably 1.0 to 2.5 times the mole of the reactive derivative in the carboxyl group of general metals. This reaction may be carried out normally at -50 to 100°C, preferably -20 to 70°C, for 5 minutes to 30 hours.
一般式(VI)で表わされる化合物またはその塩を一般
式(I[)で表わされる化合物またはその塩に誘導する
には、一般式(VI)で表わされる化合物またはその塩
を、たとえば、含水溶媒中p−トルエンスルホン酸また
はアニソール中トリフルオロ酢酸を用いて部分的にカル
ボキシル保護形成基を脱離およヒ脱カルボキシル化すれ
ばよい。In order to derive the compound represented by general formula (VI) or a salt thereof into a compound represented by general formula (I[) or a salt thereof, the compound represented by general formula (VI) or a salt thereof is treated with The carboxyl protection-forming group may be partially removed and decarboxylated using p-toluenesulfonic acid or trifluoroacetic acid in anisole.
また、一般式(n)で表わされる化合物またはその塩に
おいて、R2がヒドロキシル基またはハロゲン原子であ
る場合は、つぎに示す方法によって他の本発明化合物へ
導くこともできる。Furthermore, in the compound represented by general formula (n) or a salt thereof, when R2 is a hydroxyl group or a halogen atom, it can also be led to other compounds of the present invention by the method shown below.
(以下余白)
1l−
(I[a)またはその塩 (
IIb)(ITf)またはその塩
(Ile)=12=
また、一般式(■)で表わされる化合物の塩としては、
一般式(I)および(II)で表わされる化合物の酸性
基における塩で説明したと同様の塩が、さらに一般式(
■)で表わされる化合物の塩としては、一般式(I)お
よび(n)で表わされる化合物の塩基性基における塩で
説明したと同様の塩が挙げられる。(Left below) 1l- (I[a) or its salt (
IIb) (ITf) or its salt
(Ile)=12= Also, as a salt of the compound represented by the general formula (■),
The same salts as those explained for the acidic group salts of the compounds represented by general formulas (I) and (II) can be further added to the general formulas (
Examples of the salts of the compounds represented by (2) include the same salts as explained for the basic group salts of the compounds represented by formulas (I) and (n).
(1)一般式(IIb )で表わされる化合物の製法(
アルキル化)
一般式(nb)で表わされる化合物は、一般式(I[a
)で表わされる化合物またはその塩をアルキル什反応に
付すことにより得ることができる。(1) Method for producing a compound represented by general formula (IIb) (
alkylation) The compound represented by the general formula (nb) is a compound represented by the general formula (I[a
) or a salt thereof can be obtained by subjecting it to an alkyl reaction.
使用されるアルキル化剤としては特に限定されないが、
好ましいものとして、ジアゾアルカン、硫酸ジアルキル
およびハロゲン化アルキルなどが挙げられる。The alkylating agent used is not particularly limited, but
Preferred examples include diazoalkanes, dialkyl sulfates, and alkyl halides.
(イ) ジアゾアルカンによるアルキル化一般式(II
Ib)で表わされる化合物は、一般式(IIa )で表
わされる化合物にジアゾアルカンを反応させることによ
って得ることができる。本反応を溶媒中で行う場合、使
用される溶媒としては、反応に悪影響を与えないもので
あれば特に限定されないが、具体的には、メタノール、
エタノール、2−プロパツールナトのアルコール類;ジ
エチルエーテル、テトラヒドロフラン、ジオキサンなど
のエーテル類;アセトン、メチルエチルケトンなどのケ
トン類;酢酸メチル、酢酸エチルなどのエステル類;ベ
ンゼン、トルエンなどの芳香族炭化水素類などが挙げら
れる。これらの溶媒を2種若しくはそれ以上混合して使
用してもよい。ジアゾアルカンとしては、たとえば、ジ
アゾメタン、ジアゾエタンなどが挙げられ、その使用量
は、一般式(IIa )で表わされる化合物に対して等
モル以上、好ましくは1.0〜1.5倍モルである。本
反応は通常O〜50℃、好ましくは0〜25℃で、5分
〜30時間実施すればよい。(a) Alkylation with diazoalkane General formula (II
The compound represented by Ib) can be obtained by reacting the compound represented by the general formula (IIa) with a diazoalkane. When this reaction is carried out in a solvent, the solvent used is not particularly limited as long as it does not adversely affect the reaction, but specifically, methanol,
Alcohols such as ethanol and 2-propanato; ethers such as diethyl ether, tetrahydrofuran, and dioxane; ketones such as acetone and methyl ethyl ketone; esters such as methyl acetate and ethyl acetate; aromatic hydrocarbons such as benzene and toluene Examples include. Two or more of these solvents may be used in combination. Examples of the diazoalkane include diazomethane and diazoethane, and the amount used is equal to or more, preferably 1.0 to 1.5 times the mole of the compound represented by the general formula (IIa). This reaction may be carried out usually at 0 to 50°C, preferably 0 to 25°C, for 5 minutes to 30 hours.
の塩に、脱酸剤の存在下または不存在下、硫酸ジアルキ
ルを反応させることによって得ることができる。本反応
を溶媒中で行う場合、使用される溶媒としては、反応に
悪影響を与えないものであれば特に限定されないが、具
体的には、水:アセトン、メチルエチルケトンなどのケ
トン類;酢酸メチル、酢酸エチルなどのエステル類;テ
トラヒドロフラン、ジオキサンなどのエーテル類+N、
N−ジメチルホルムアミド、N、N−ジメチルアセトア
ミドなどのアミド類;ジメチルスルホキシドなどのスル
ホキシド類などが挙げられる−これらの溶媒を2種若し
くはそれ以上混合して使用してもよい。硫酸ジアルキル
としては、たとえば、硫酸ジメチル、硫酸ジエチルなど
が挙げられる。脱酸剤としては、たとえば、水酸化アル
カリ、炭酸アルカリなどの無機塩基が挙げられる。can be obtained by reacting a salt of with dialkyl sulfate in the presence or absence of an acid absorber. When this reaction is carried out in a solvent, the solvent used is not particularly limited as long as it does not adversely affect the reaction, but specifically, water: ketones such as acetone and methyl ethyl ketone; methyl acetate, acetic acid Esters such as ethyl; ethers such as tetrahydrofuran and dioxane + N,
Examples include amides such as N-dimethylformamide and N,N-dimethylacetamide; sulfoxides such as dimethylsulfoxide; two or more of these solvents may be used in combination. Examples of the dialkyl sulfate include dimethyl sulfate and diethyl sulfate. Examples of the deoxidizing agent include inorganic bases such as alkali hydroxide and alkali carbonate.
本反応において硫酸ジアルキルおよび所望に応じて使用
される脱酸剤の使用量は、一般式(IIa)で表わされ
る化合物またはその塩に対してそれぞれ等モル以上、好
ましくは1〜2倍モルである。本反応は通常0〜150
℃、好ましくは0〜50℃で、5分〜30時間実施すれ
ばよい。In this reaction, the amount of the dialkyl sulfate and the deoxidizing agent used as desired is equal to or more, preferably 1 to 2 times the mole of the compound represented by the general formula (IIa) or its salt. . This reaction is usually 0 to 150
What is necessary is just to carry out at 0-50 degreeC, preferably 5 minutes to 30 hours.
、Ci ハロゲン化アルキルによるアルキル仕一般式
(nb)で表わされる化合物は、脱酸剤の存在下または
不存在下、一般式(I[a)で表わされる化合物または
その塩に710ゲン化アルキルを反応させることによっ
て得ることができる。本反応を溶媒中で行う場合、使用
される溶媒としては、反応に悪影響を与えないものであ
れば特に限定されないが、具体的には、水;塩化メチレ
ン、クロロホルムfxトノハロゲン什炭化水素類;ジエ
チルエーテル、テトラヒドロフラン、ジオキサンなどの
エーテル類;N、N−ジメチルホルムアミド、N。, Ci Alkyl halogenation The compound represented by the general formula (nb) is prepared by adding a 710 alkyl halide to the compound represented by the general formula (I[a) or a salt thereof in the presence or absence of a deoxidizing agent. It can be obtained by reaction. When this reaction is carried out in a solvent, the solvent used is not particularly limited as long as it does not adversely affect the reaction, but specifically, water; methylene chloride, chloroform fx, tonohalogen, hydrocarbons; diethyl Ethers such as ether, tetrahydrofuran and dioxane; N,N-dimethylformamide, N.
N−ジメチルアセトアミドなどのアミド類;ジメチルス
ルホキシドなどのスルホキシド類などが挙げられる。こ
れらの溶媒は2種若しくはそれ以上混合して使用しても
より0ハロゲン仕アルキルとしては、たとえば、ヨウ化
メチル、臭化メチル、臭化エチルなどが挙げられる。脱
酸剤としては、たとえば、炭酸アJL/ 力IJなどの
無機塩基、またはトリメチルアミン、トリエチルアミン
、トリブチルアミン、ピリジン、N−メチルピペリジン
、N−メチルモルホリン、ルチジン、コリジンなどの有
機塩基が挙げられる。Amides such as N-dimethylacetamide; sulfoxides such as dimethyl sulfoxide, and the like. Two or more of these solvents may be used as a mixture. Examples of the halogenated alkyl include methyl iodide, methyl bromide, and ethyl bromide. Examples of the deoxidizing agent include inorganic bases such as carbonic acid and organic bases such as trimethylamine, triethylamine, tributylamine, pyridine, N-methylpiperidine, N-methylmorpholine, lutidine, and collidine.
本反応において、ハロゲン化アルキルおよび所望に応じ
て使用される脱酸剤の使用量は、一般式(]Ta)で表
わされる化合物またはその塩に対してそれぞれ等モル以
上、好ましくは1〜2倍モルである。本反応は通常O〜
150℃、好ましくは0〜50℃で、5分〜30時間実
施すればよい。In this reaction, the amount of the alkyl halide and the deoxidizing agent used if desired is equal to or more, preferably 1 to 2 times the amount of the compound represented by the general formula (]Ta) or its salt. It is a mole. This reaction is usually O~
What is necessary is just to carry out at 150 degreeC, preferably 0-50 degreeC for 5 minutes to 30 hours.
(2) 一般式(ffc)で表わされる化合物の製法
(スルホニル化)
一般式(I[c )で表わされる化合物は、一般式(I
Ia)で表わされる化合物またはその塩に、脱酸剤の存
在下または不存在下、スルホニル化剤を反応させること
によって得ることができる。(2) Process for producing a compound represented by the general formula (ffc) (sulfonylation) The compound represented by the general formula (I[c)
It can be obtained by reacting the compound represented by Ia) or a salt thereof with a sulfonylating agent in the presence or absence of a deoxidizing agent.
本反応を溶媒中で行う場合、使用される溶媒としては、
反応に悪影響を与えないものであれば特に限定されない
が、具体的には、水;ベンゼン、トルエン、キシレンな
どの芳香族炭化水素類;ジオキサン、テトラヒドロフラ
ン、アニソール、シエチレングリコールジメチルエーテ
ルナトノエーテル類;塩化メチレン、クロロホルム、ジ
クロロエタンなどのハロゲン什炭什水素類;アセトン、
メチルエチルケトン−/xどのケトン類;N、N−ジメ
チルホルムアミド−N。When this reaction is carried out in a solvent, the solvent used is
There is no particular limitation as long as it does not adversely affect the reaction, but specifically, water; aromatic hydrocarbons such as benzene, toluene, and xylene; dioxane, tetrahydrofuran, anisole, thiethylene glycol dimethyl ether natonoethers; chloride Halogenated hydrocarbons such as methylene, chloroform, dichloroethane; acetone,
Methyl ethyl ketone-/x which ketones; N,N-dimethylformamide-N.
N−ジメチルアセトアミドなどのアミド類;ジメチルス
ルホキシドなどのスルホキシド類;ヘキサメチルホスホ
ルアミド;ピリジンなどが挙げられる。これらの溶媒は
2種若しくはそれ以上混合して使用してもよい。ズルホ
ニル什剤トしては、たとえば、メタンスルホニルクロリ
ド、エタンスルホニルクロリド、1−メチルエタンスル
ホニルクロリド、1.1−ジメチルエタンスルホニルク
ロリドなどのアルカンスルホニルハロケエト類、ベンゼ
ンスルホニルクロIJ)”、トルエンスルホニルクロリ
ド、2−二トロベンゼンスルホニルクロリド、メシチレ
ンスルホニルクロリド、2,4.6−)リイソプロビル
ベンゼンスルホニルクロリド、ナフタレンスルホニルク
ロリドなどのアレーンスルホニルハロゲート類、ベンゼ
ンスルホン酸無水物、トルエンスルホン酸無水物、メタ
ンスルホン酸無水物などのアルカン−またはアレーン−
スルホン酸無水物などが挙げられる。脱酸剤としては、
たとえば、トリエチルアミン、シイツブaピルエチル7
ミン、1.8−ジアザビシクロ−[5,4,0]−ウ
ンデセ−7−エン(DBU)、ビリシソ、カリウ−IA
tert。Amides such as N-dimethylacetamide; sulfoxides such as dimethyl sulfoxide; hexamethylphosphoramide; and pyridine. These solvents may be used in combination of two or more. Sulfonyl additives include, for example, alkanesulfonyl halokeates such as methanesulfonyl chloride, ethanesulfonyl chloride, 1-methylethanesulfonyl chloride, 1,1-dimethylethanesulfonyl chloride, benzenesulfonyl chloride, toluenesulfonyl Chloride, 2-nitrobenzenesulfonyl chloride, mesitylenesulfonyl chloride, 2,4.6-)lyisoprobylbenzenesulfonyl chloride, arenesulfonyl halogenates such as naphthalenesulfonyl chloride, benzenesulfonic anhydride, toluenesulfonic anhydride, Alkanes or arenes such as methanesulfonic anhydride
Examples include sulfonic acid anhydride. As a deoxidizing agent,
For example, triethylamine, pyruethyl 7
min, 1,8-diazabicyclo-[5,4,0]-undec-7-ene (DBU), viriciso, cariou-IA
tert.
−ブトキシド、炭酸カリウム、炭酸ナトリウム、水素化
す) IJウムなどの有機または無機塩基が挙げられる
。organic or inorganic bases such as -butoxide, potassium carbonate, sodium carbonate, hydride, and the like.
スルホニル化剤および所望に応じて使用される脱酸剤の
使用量は、一般式(mn )で表わされる化合物または
その塩に対してそれぞれ等モル以上、好ましくは1〜2
倍モルである。本反応は通常−10〜150℃、好まし
くは0〜80℃で、5分〜30時間実施すればよい。The amount of the sulfonylating agent and the deoxidizing agent used as desired is equal to or more, preferably 1 to 2 moles, relative to the compound represented by the general formula (mn) or its salt.
It is twice the mole. This reaction may be carried out normally at -10 to 150°C, preferably at 0 to 80°C, for 5 minutes to 30 hours.
(3)一般式(nd)で表わされる化合物の製法(チオ
ール化)
一般式(nd)で表わされる化合物は、一般式(me
)または(IIe)で表わされる化合物に、脱酸剤の存
在下または不存在下、一般式(■)で表わされるチオー
ル類またはその塩を反応させることによって得ることが
できる。(3) Manufacturing method (thiolation) of the compound represented by the general formula (nd) The compound represented by the general formula (nd) is manufactured by the general formula (me
) or (IIe) with a thiol represented by the general formula (■) or a salt thereof in the presence or absence of a deoxidizing agent.
本反応全溶媒中で行う場合、使用される溶媒としでは1
反応に悪影響を与えないものであれば特に限定されない
が、具体的には、ベンゼン、トルエン、キシレンなどの
芳香族炭化水素類ニジオキサン、テトラヒドロフラン、
アニソール、ジエチレングリコールジエチルエーテルな
どのエーテル類;塩化メチレン、クロロホルム、ジクロ
ロエタンなどのハロゲン化炭化水素類;N。When this reaction is carried out in all solvents, the solvent used is 1
There is no particular limitation as long as it does not adversely affect the reaction, but specific examples include aromatic hydrocarbons such as benzene, toluene, and xylene, dioxane, tetrahydrofuran,
Ethers such as anisole and diethylene glycol diethyl ether; halogenated hydrocarbons such as methylene chloride, chloroform, and dichloroethane; N.
N−ジメチルホルムアミド、N、N−ジメチルアセトア
ミドなどのアミド類;ジメチルスルホキシドなどのスル
ホキシド類などが挙げられる。Amides such as N-dimethylformamide and N,N-dimethylacetamide; sulfoxides such as dimethyl sulfoxide; and the like.
これらの溶媒は2種若しくはそれ以上混合して使用して
もよい。These solvents may be used in combination of two or more.
一般式(■)で表わされるチオール類としては、たとえ
ば、メタンチオール、エタンチオール、n−プロパンチ
オール、イソブタンチオール、ペンタンチオール、ヘキ
サンチオール、ヘプタンチオール、オクタンチオール、
ドデカンチオール、チオフェノール、ナフタレンチオー
ルなどが挙げられる。脱酸剤としては、(2)で挙げた
と同様の無機または有機塩基が挙げられる。Examples of thiols represented by the general formula (■) include methanethiol, ethanethiol, n-propanethiol, isobutanethiol, pentanethiol, hexanethiol, heptanethiol, octanethiol,
Examples include dodecanethiol, thiophenol, and naphthalenethiol. Examples of the deoxidizing agent include the same inorganic or organic bases mentioned in (2).
たは(IIe )で表わされる化合物に対してそれぞれ
等モル以上、好ましくは1〜2倍モルである。or the compound represented by (IIe), respectively, in an equimolar amount or more, preferably 1 to 2 times the molar amount.
本反応は通常0〜150℃、好ましくは0〜70℃で、
5分〜30時間実施すればよい。This reaction is usually carried out at a temperature of 0 to 150°C, preferably 0 to 70°C,
It may be carried out for 5 minutes to 30 hours.
(4) 一般式(IIf )で表わされる化合物また
はその塩の製法
一般式(If )で表わされる化合物またはその塩は、
一般式(IIc )または(Ice)で表わされる化合
物に、脱酸剤の存在T1たは不存在下に。(4) Method for producing the compound represented by the general formula (IIf) or its salt The compound represented by the general formula (If) or its salt is:
A compound represented by the general formula (IIc) or (Ice) in the presence or absence of a deoxidizer.
一般式(vIll)で表わされるアミン類またはその塩
を反応させることによって得ることができる。It can be obtained by reacting amines represented by the general formula (vIll) or salts thereof.
本反応を溶媒中で行う場合、使用される溶媒としては、
反応に悪影響を与えないものであれば特に限定されない
が、具体的には、ベンゼン、トルエン、キシレンなどの
芳香族炭化水素類;メタノール、エタノール、n−グロ
パノール、2−グロパノール、n−ブタノール、イソブ
タノール、tert、−ブタノールなどのアルコール類
;ジオキサン、テトラヒドロフラン、アニソール、ジエ
チレングリコールなど(Dエーテル類;塩化メチレン、
クロロホルム、ジクロロエタンなどのハロゲン化炭化水
素類;N、N−ジメチルホルムアミド、N、N−ジメチ
ルアセトアミドなどのアミド類;ジメチルスルホキシド
などのスルホキシド類などが挙げられる。これらの溶媒
は2種若しくはそれ以上混合して使用してもよい。また
、脱酸剤としては、(2)で挙げたと同様の無機または
有機塩基が挙げられる。When this reaction is carried out in a solvent, the solvent used is
There is no particular limitation as long as it does not adversely affect the reaction, but specific examples include aromatic hydrocarbons such as benzene, toluene, and xylene; methanol, ethanol, n-gropanol, 2-gropanol, n-butanol, and Alcohols such as butanol, tert, -butanol; dioxane, tetrahydrofuran, anisole, diethylene glycol, etc. (D ethers; methylene chloride,
Examples include halogenated hydrocarbons such as chloroform and dichloroethane; amides such as N,N-dimethylformamide and N,N-dimethylacetamide; and sulfoxides such as dimethylsulfoxide. These solvents may be used in combination of two or more. Furthermore, examples of the deoxidizing agent include the same inorganic or organic bases as mentioned in (2).
一般式(■)で表わされるアミン類またはその塩の使用
量は脱酸剤を用いない場合、一般式(IIc )または
(Ile)で表わされる化合物に対して、好ましくは2
〜5倍モルであるが、脱酸剤を適宜使用することによっ
て一般式(■)で表わされるアミン類またはその塩の使
用量を減らすことができる。本反応は通常O〜150℃
、好ましくは15〜100℃で、5分〜30時間実施す
ればよい。When no deoxidizing agent is used, the amount of the amine represented by the general formula (■) or its salt is preferably 2
The amount of the amine represented by formula (■) or its salt can be reduced by appropriately using a deoxidizing agent. This reaction is usually 0 to 150℃
, preferably at 15 to 100°C for 5 minutes to 30 hours.
また、本発明化合物を製造するための原料である一般式
(III)で表わされる化合物は、たとえば、つぎのよ
うにして得ることができる。Further, the compound represented by general formula (III), which is a raw material for producing the compound of the present invention, can be obtained, for example, as follows.
(以下余白)
(Illa)またはその塩
(me)tたはその塩
また、上記式(Ha )〜(me ) 、 (IX)
、(XI)および(■)における化合物の塩としては、
一般式(I)および(n)で表わされる化合物で説明し
たと同様の塩が挙げられる。(Left below) (Illa) or a salt thereof (me) or a salt thereof, or the above formula (Ha) to (me), (IX)
, (XI) and (■),
Examples include the same salts as explained for the compounds represented by general formulas (I) and (n).
一般式(5)で表わされる化合物またはその塩は、英国
特許第1409987号に記載の方法に準じて一般式(
IX)で表わされる化合物またはその塩に一般式(X)
で表わされる化合物を反応させることによって得ること
ができる。A compound represented by the general formula (5) or a salt thereof can be prepared by the general formula (5) according to the method described in British Patent No. 1409987.
General formula (X) to the compound represented by IX) or its salt
It can be obtained by reacting a compound represented by
また、一般式(■)で表わされる化合物またはその塩は
、プレタンeド・うφソシエテ・シミク・トウーフラン
ス(Bull、Soc、Chim、 Fr、)1165
〜1169(1975)に記載の方法に従って製造する
ことができるO
一般式(■a)で表わされる化合物またはその塩ま、縮
合剤の存在下または不存在下、一般式(X[)で表わさ
れる化合物またはその塩に、一般式(■)で表わされる
化合物まfcはその塩を反応させると二によって得るこ
とができる。In addition, the compound represented by the general formula (■) or a salt thereof is prepared by Pretane de Uφ Société Chimique Tou France (Bull, Soc, Chim, Fr,) 1165
1169 (1975), a compound represented by the general formula (■a) or a salt thereof, in the presence or absence of a condensing agent, a compound represented by the general formula (X[) When a compound or a salt thereof is reacted with a compound represented by the general formula (■), fc can be obtained by the following procedure.
本反応を溶媒中で行う場合、使用される溶媒としては、
反応に悪影響を与えな^ものであれば特に限定されない
が、具体的には、水;メタノール。When this reaction is carried out in a solvent, the solvent used is
There are no particular limitations as long as it does not adversely affect the reaction, but specifically, water; methanol.
エタノール、2−7’ロバノール、ブタノール、エチレ
ングリコール、メチルセロソルブなどのアルコール類;
ベンゼン、トルエンなどの芳香族炭化水素類;塩化メチ
レン、クロロホルム、ジクロロエタンなどのハロゲン化
炭化水素類;テトラヒドロフラン、ジオキサン、アニソ
−ル、ジエチレングリコールジメチルエーテル、ジメチ
ルセロソルブなどのエーテル類;アセトニトリルなどの
ニトリル類;アセトン、メチルエチルケトンなどのケト
ン類;酢酸エチル、酢酸メチルなどのエステル類;N、
N−ジメチルホルムアミド、N、N−ジメチルアセトア
ミドなどのアミド類ニジメチルスルホキシドなどのスル
ホキシド類などが挙げられる。これらの溶媒を2種若し
くはそれ以上混合して使用してもよい。Alcohols such as ethanol, 2-7' lovanol, butanol, ethylene glycol, methyl cellosolve;
Aromatic hydrocarbons such as benzene and toluene; Halogenated hydrocarbons such as methylene chloride, chloroform, and dichloroethane; Ethers such as tetrahydrofuran, dioxane, anisole, diethylene glycol dimethyl ether, and dimethyl cellosolve; Nitriles such as acetonitrile; Acetone , Ketones such as methyl ethyl ketone; Esters such as ethyl acetate and methyl acetate; N,
Examples include amides such as N-dimethylformamide and N,N-dimethylacetamide, and sulfoxides such as dimethyl sulfoxide. Two or more of these solvents may be used in combination.
縮合剤としては、たとえば、水酸化ナトリウム、水酸化
カリウム、カリウムtert、−ブトキシド、水素化ナ
トリウム、ナトリウムメトキシド、ナトリウムエトキシ
ド、カリウムメトキシド、カリウムエトキシドなどが誉
げられる。Suitable condensing agents include, for example, sodium hydroxide, potassium hydroxide, potassium tert, -butoxide, sodium hydride, sodium methoxide, sodium ethoxide, potassium methoxide, potassium ethoxide, and the like.
本反応において、一般式(■)で表わされる化合物また
はその塩の使用部−は、特に限定されないが、通常、一
般式(XI)で表わされる化合物またはその塩に対して
等モル以上、好ましくは1,0〜3.0倍モルである。In this reaction, the amount of the compound represented by the general formula (■) or its salt used is not particularly limited, but is usually at least equimolar to the compound represented by the general formula (XI) or its salt, preferably It is 1.0 to 3.0 times the mole.
1だ、本反応は通常O〜150℃、好ましくは25〜1
00℃で、5分〜30時間実施すればよい。1, this reaction is usually carried out at 0 to 150°C, preferably 25 to 1
What is necessary is just to carry out at 00 degreeC for 5 minutes - 30 hours.
マタ、アルキル什、スルホニル化、チオール化および一
般式(IIIc)で表わされる化合物またはその塩を一
般式(IITe)で表わされる化合物またはその塩へ誘
導する方法は前述したと同様の方法によって行うことが
できる。The method for converting a compound represented by formula (IIIc) or a salt thereof into a compound represented by general formula (IITe) or a salt thereof may be carried out by the same method as described above. I can do it.
また、一般式(Illc)で表わされる化合物またはそ
の塩のうち、R10が・・ロゲン原子である場合は、一
般式(Illa)で表わされる化合物またはその塩にハ
ロゲン化剤を反応させることによって得ることができる
。この反応を溶媒中で行う場合、使用される溶媒として
は、反応に悪影響を与えないものであれば特に限定され
ないが、具体的には、ベンゼン、トルエン、キシレンな
どの芳香族炭化水累類;塩化メチレン、クロロホルム、
ジクロロエタンなどのハロゲン化炭化水素類;N、N−
ジメチルホルムアミド%N、N−ジメチルアセトアミド
などのアミド類などが挙げられる。これらの溶媒は2種
若しくはそれ以上混合して使用してもよい。ハロゲン化
剤としては、たとえば、オキシ塩化リン、オキシ臭化リ
ン、五塩什リン、五臭化リン、三塩化リン、塩化チオニ
ル、ホスゲンナトybi挙げられ、これらの試剤を2種
若しくはそれ丹上混合して使用してもよく、これらのハ
ロゲン化剤は溶媒として用いてもよい。ハロゲン化剤は
使用量は、一般式(IIIa)で表わされる化合物また
はその塩に対して等モル以上である。本反応は通常0〜
150℃、好ましくけ50〜110℃で、30分〜30
時間実施すればよい。In addition, in the compound represented by the general formula (Illc) or a salt thereof, when R10 is a halogen atom, it can be obtained by reacting the compound represented by the general formula (Illa) or a salt thereof with a halogenating agent. be able to. When this reaction is carried out in a solvent, the solvent used is not particularly limited as long as it does not adversely affect the reaction, but specifically, aromatic hydrocarbons such as benzene, toluene, and xylene; methylene chloride, chloroform,
Halogenated hydrocarbons such as dichloroethane; N, N-
Examples include amides such as dimethylformamide%N, N-dimethylacetamide, and the like. These solvents may be used in combination of two or more. Examples of the halogenating agent include phosphorus oxychloride, phosphorus oxybromide, phosphorus pentachloride, phosphorus pentabromide, phosphorus trichloride, thionyl chloride, and phosgenate, and two or more of these agents may be used. These halogenating agents may also be used as solvents. The amount of the halogenating agent used is at least equimolar to the compound represented by general formula (IIIa) or its salt. This reaction is usually 0~
150℃, preferably 50-110℃, 30 minutes to 30 minutes
All you have to do is time it.
このようにして得られた一般式(Ha)〜(IIIe)
で表わされる化合物またはそれらの塩は、自体公知の方
法により、一般式(III)で表わされる化合物のカル
ボキシル基における反応性誘導体へ変換することができ
る。General formulas (Ha) to (IIIe) thus obtained
The compound represented by or a salt thereof can be converted into a reactive derivative at the carboxyl group of the compound represented by general formula (III) by a method known per se.
以上説明したそれぞれの反応に′よって得つれる化合物
は常法によって単離または分離することができ、また単
離または分離することなくつぎの反応に使用することも
できる。The compounds obtained in each of the reactions described above can be isolated or separated by conventional methods, or can be used in the next reaction without being isolated or separated.
このようにして得られた一般式(n)で表わされる化合
物またはその塩は、たとえば、つぎに示すルートによっ
て一般式(I)で表わされる化合物またはその塩へ誘導
することができる。The compound represented by the general formula (n) or a salt thereof thus obtained can be derived into a compound represented by the general formula (I) or a salt thereof, for example, by the route shown below.
(以下余白)
=30−
(III)またはその塩
■
(I)またはその塩
上述した工程にお匹て、一般式(X]Ir)で表わされ
る化合物またはその塩のR2がヒドロキシル基または置
換基を有していてもよいアルコキシ基の場合は、これを
たとえば、R2が対応するノ・ロゲン原子あるいは置換
基を有していてもよいアレーンスルホニルオキシ基タは
アレーンスルホニルオキシ基である一般式α■)で表わ
される化合物またはその塩に変換した後、一般式(■)
で表わされる化合物またはその塩を作用させ、一般式(
I)で表わされる化合物またはその塩へ誘導することが
できる。また、一般式(X[II)で表わされる化合物
またはその塩のR2が置換基を有していてもよいアルキ
ルチオまたはアリールチオの場合は、これをR2が対応
するスルホキシまたはスルホンである一般式(■)で表
わされる化合物またはその塩に変換した後、一般式(■
)で表わされる化合物またはその塩を作用させ、一般式
(I)で表わされる仕合物丑たばその塩に誘導すること
ができる。(Left below) =30- (III) or a salt thereof ■ (I) or a salt thereof In the above-mentioned process, R2 of the compound represented by the general formula (X]Ir) or a salt thereof is a hydroxyl group or a substituent. In the case of an alkoxy group which may have an alkoxy group, for example, R2 is a corresponding norogen atom or an arenesulfonyloxy group which may have a substituent. After converting to the compound represented by (■) or its salt, the general formula (■)
The compound represented by or its salt is reacted with the general formula (
The compound represented by I) or a salt thereof can be derived. In addition, in the case where R2 of the compound represented by the general formula (X[II) or a salt thereof is alkylthio or arylthio which may have a substituent, this is replaced by the general formula (■ ) or its salt, the general formula (■
) or a salt thereof can be reacted with the compound represented by formula (I) to induce a salt of shikadobutaba represented by general formula (I).
一般式αm)で表わされる化合物の塩としては、一般式
(I)および(n)で表わされる化合物で説明したと同
様の塩が挙げられる。Examples of the salt of the compound represented by the general formula αm) include the same salts as explained for the compounds represented by the general formulas (I) and (n).
つぎに本発明を実施例および参考例を挙げて説明するが
、本発明はこれに限定されるものではない。Next, the present invention will be explained with reference to Examples and Reference Examples, but the present invention is not limited thereto.
実施例1
2−(2,4−ジフルオロフェニルアミノ)−5−フル
オロ−6−ヒドロキシニコチン酸1.0Ofを無水テト
ラヒドロフラン40−に懸濁させ、水冷下でN、N’−
力ルボニルジイミダゾール0,8611添加し、室温で
185時間反応させる。ついで、エトキシカルボニル酢
酸のマグネシウム塩1.601を添加し、60℃で3時
間反応させた後、反応m’を酢eエチル80−および水
80ゴの混合液に加え、6N−塩酸でpH2,0に調整
する。有機層を分取し、飽和炭酸水素ナトリウム水溶液
40ゴおよび水40−で順次洗浄した後、水40−を加
え、6N−塩酸でpH2,0に調整する。有機層を分取
し、水40ゴおよび飽和食塩水40ゴで順次洗浄した後
、無水硫酸マグネシウムで乾燥させる。Example 1 1.0Of 2-(2,4-difluorophenylamino)-5-fluoro-6-hydroxynicotinic acid was suspended in anhydrous tetrahydrofuran 40-, and N,N'- was added under water cooling.
0.8611 l of carbonyl diimidazole was added and the mixture was allowed to react at room temperature for 185 hours. Next, 1.601 ml of magnesium salt of ethoxycarbonylacetic acid was added, and the reaction was carried out at 60°C for 3 hours. The reaction m' was then added to a mixture of 80 ml of ethyl acetate and 80 ml of water, and the pH was adjusted to 2 with 6N hydrochloric acid. Adjust to 0. The organic layer is separated and washed successively with 40 g of saturated aqueous sodium bicarbonate solution and 40 g of water, then 40 g of water is added, and the pH is adjusted to 2.0 with 6N hydrochloric acid. The organic layer is separated, sequentially washed with 40 g of water and 40 g of saturated brine, and then dried over anhydrous magnesium sulfate.
減圧下に溶媒を留去し、得られた結晶性物質にジエチル
エーテル4ゴを加えて結晶を戸数すれば、融点161〜
162℃を示す2− (2,4−ジフルオロフェニルア
ミノ)−5−フルオロ−6−ヒドロキシニコチノイル酢
酸エチルエステル0143f!(収率34.5%)を得
る。The solvent is distilled off under reduced pressure, and diethyl ether is added to the resulting crystalline substance to form crystals, which gives a melting point of 161~
2-(2,4-difluorophenylamino)-5-fluoro-6-hydroxynicotinoylacetic acid ethyl ester 0143f exhibiting 162°C! (yield 34.5%).
IR(KBr)B−1;νc =01725.1665
NMR(CDCJa )δ値;
1.29(3H,t、J=7Hz)、3.74(2’H
,s)。IR(KBr)B-1; νc =01725.1665
NMR (CDCJa) δ value; 1.29 (3H, t, J = 7Hz), 3.74 (2'H
,s).
4.20 (2H,q 、 J=7Hz ) 、 6
.57〜7.69(4H。4.20 (2H,q, J=7Hz), 6
.. 57-7.69 (4H.
m)、10.17(IH,bs)、11.52(IH,
bs)同様にしてつき゛の化合物を得る。m), 10.17 (IH, bs), 11.52 (IH,
bs) Compound 2 is obtained in the same manner.
05−フルオロ−2−(4−フルオロフェニルアミノ)
−6−ヒドロキシニコチノイル酢酸エチルエステル
融点; 185℃(分解)(再結溶媒;酢酸エチル)I
R(KB r )、、、−1;νc=o 1715
,1685NiviR(CDCI3)δ値;
1.30(3H,t、J=7Hz)、 3.75(2
H,s)。05-Fluoro-2-(4-fluorophenylamino)
-6-Hydroxynicotinoyl acetic acid ethyl ester melting point; 185°C (decomposition) (reconsolidation solvent; ethyl acetate) I
R(KB r ), , -1; νc=o 1715
, 1685 NiviR (CDCI3) δ value; 1.30 (3H, t, J = 7Hz), 3.75 (2
H,s).
4.25(2H,q、J=7Hz)、 7.80〜7
.34(41(、m)、 7.48(IH,d、J=
11Hz)。4.25 (2H, q, J=7Hz), 7.80~7
.. 34 (41 (, m), 7.48 (IH, d, J=
11Hz).
11.68(IH,bs)
実施例2
6−クロロ−2−(2,4−ジフルオロフェニルアミノ
)−5−フルオロニコチンmo、70tを無水テトラヒ
ドロフラン30−に溶解させ、水冷下でN 、 N’−
カルボニルジイミダゾール1.13fを添加し、室温で
6時間反応させる。ついで、エトキシカルボニル酢酸の
マグネシウム塩0.99 fを添加し、55℃で2時間
反応させた後、反応液を酢酸エチル75mおよび水65
a/の混合液に加え116N−塩酸でp’H2,oに調
整する。有機層を分取し、水30−を加え、飽和炭酸水
素ナトリウム水溶液でpH7,5に調整する。有機層を
分取し、水30dおよび飽和食塩水30−で順次洗浄し
た後、無水硫酸マグネシウムで乾燥させる。減圧下に溶
媒を留去し、得られた残留物をカラムクロマトグラフィ
ー〔和光シリカゲルC−200、溶出溶媒;ベンゼン〕
で精製すれば、2−〔6−クロロ2−(2,4−ジフル
オロフェニルアミ/)−s−フルオロニコチノイル]f
f[エチルエステル0.68r(収率789係)′fi
:得る。これをジイソプロピルエーテルで再結晶して融
点92,5〜93℃を示す結晶全相る。11.68 (IH, bs) Example 2 6-chloro-2-(2,4-difluorophenylamino)-5-fluoronicotine mo, 70t was dissolved in anhydrous tetrahydrofuran 30-, and N and N' were dissolved under water cooling. −
Add 1.13 f of carbonyldiimidazole and react at room temperature for 6 hours. Next, 0.99 f of magnesium salt of ethoxycarbonylacetic acid was added and the reaction was allowed to proceed at 55°C for 2 hours.
Add to the mixed solution of a/ and adjust to p'H2,o with 116N-hydrochloric acid. The organic layer is separated, 30% of water is added, and the pH is adjusted to 7.5 with a saturated aqueous sodium bicarbonate solution. The organic layer is separated, washed successively with 30 d of water and 30 d of saturated brine, and then dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and the resulting residue was subjected to column chromatography [Wako silica gel C-200, elution solvent: benzene]
2-[6-chloro2-(2,4-difluorophenylami/)-s-fluoronicotinoyl] f
f[ethyl ester 0.68r (yield 789)'fi
:obtain. This was recrystallized from diisopropyl ether to give a crystalline phase having a melting point of 92.5 to 93°C.
I R(KB r )cm−″1;シc=o1745N
MR(CDC13)δ値;
1.31(3H,t、J=7Hz)、3.97(2H,
s)。I R (KB r ) cm-″1; c=o1745N
MR (CDC13) δ value; 1.31 (3H, t, J=7Hz), 3.97 (2H,
s).
4.25(2H,q、J=7Hz)、 6.65〜7
.35(2H。4.25 (2H, q, J=7Hz), 6.65~7
.. 35 (2H.
m)、7.85(in、d、J=9Hz)、8.00〜
8.50(IH,m)、10.91(IH,bs)同様
にして、つさ゛の化合物を得る。m), 7.85 (in, d, J=9Hz), 8.00~
In the same manner as in 8.50 (IH, m) and 10.91 (IH, bs), a compound of Tsa is obtained.
02−[2−(2,4−ジフルオロフェニルアミノ)−
5−フルオロ−6−メドキシニコチノイル〕酢酸エチル
エステル
融点; 149〜150℃(再結溶媒;ベンゼン)IR
(KBr )crc” iシc=o1745NMR(C
DCIa )δ値;
1.30(3H,t、J=7Hz)、 3.90(2
H,s)。02-[2-(2,4-difluorophenylamino)-
5-Fluoro-6-medoxynicotinoyl]acetic acid ethyl ester melting point; 149-150°C (recrystallization solvent: benzene) IR
(KBr)crc” ishic=o1745NMR(C
DCIa) δ value; 1.30 (3H, t, J=7Hz), 3.90 (2
H,s).
4.02 (3H,s )、 4.27 (2H,q
、J=7Hz)。4.02 (3H,s), 4.27 (2H,q
, J=7Hz).
6゜65〜7.35(2H,m)、 7.73(IH
,d。6゜65~7.35 (2H, m), 7.73 (IH
,d.
J=10Hz)、 7.90〜8.40(IH,m)
。J=10Hz), 7.90-8.40 (IH, m)
.
11.19(IH,bs)
0 2−[2−(2,4−ジフルオロフェニルアミノ)
−6−エチルチオ−5−フルオロニコチノイル〕酢酸エ
チルエステル
融点; 102.5〜103°C(再結溶媒;ジイソプ
ロピルエーテル)IR(KBr)、−71−1;シc=
o173ONMR(CDCIa)δ値;
1.29(6H,t、J=7Hz)、 3.06(2
H,q。11.19(IH, bs) 0 2-[2-(2,4-difluorophenylamino)
-6-ethylthio-5-fluoronicotinoyl]acetic acid ethyl ester melting point; 102.5-103°C (reconsolidation solvent; diisopropyl ether) IR (KBr), -71-1; c=
o173ONMR (CDCIa) δ value; 1.29 (6H, t, J = 7Hz), 3.06 (2
H,q.
J=7Hz)、 3.90(2H,s)、 4.2
2(2H。J=7Hz), 3.90 (2H, s), 4.2
2 (2H.
q、J”=7Hz)、 6.62〜7.35(2H,
m)。q, J”=7Hz), 6.62-7.35 (2H,
m).
7.52(IH,d、J=11Hz)、 7.70〜
8.20(IH,m)、 10.86(1)1.bs
)0 2−1:2−(2,4−ジフルオロフェニルアミ
ノ)−5−フルオロ−6−フェニルチオニコチノイル〕
酢酸エチルエステル
融点;132.5〜134℃(再結溶媒;酢酸エチル:
n−ヘキサン= 10 : 1 )
= 37−
I R(KB r )、、、−i ; νc=o
1725NMR(CDC13)δ値;
1.27(3H,t、J=7Hz)、 3.89(2
H,s)。7.52 (IH, d, J=11Hz), 7.70~
8.20 (IH, m), 10.86 (1) 1. bs
)0 2-1:2-(2,4-difluorophenylamino)-5-fluoro-6-phenylthionicotinoyl]
Ethyl acetate melting point: 132.5-134°C (reconsolidation solvent; ethyl acetate:
n-hexane=10:1)=37-IR(KBr),,,-i; νc=o
1725NMR (CDC13) δ value; 1.27 (3H, t, J = 7Hz), 3.89 (2
H,s).
4.20 (2H、q 、 J”7Hz ) 、 5
.98〜8.03(9H,m)、 11.12(IH
,bs)02−C2−(2,4−ジフルオロフェニルア
ミノ)−5−フルオロ−6−(2,4,6−)リメチル
ベンゼンスルホニルオキシ)ニコチノイル酢酸〕エチル
エステル
融点;160〜160.5℃(再結溶媒;ベンゼン)I
R(K B r ) 、L−’ ” ; νc=o
173QNMR(CDCIa)δ値;
1.27(3H,j、J”7Hz)、2.32(3H,
s)。4.20 (2H, q, J”7Hz), 5
.. 98-8.03 (9H, m), 11.12 (IH
, bs)02-C2-(2,4-difluorophenylamino)-5-fluoro-6-(2,4,6-)limethylbenzenesulfonyloxy)nicotinoylacetic acid]ethyl ester Melting point: 160-160.5°C (Recrystallization solvent; benzene) I
R(KBr), L-'''; νc=o
173QNMR (CDCIa) δ value; 1.27 (3H, j, J”7Hz), 2.32 (3H,
s).
2.57(6H,s)、3.90(2H,s)、4.2
0(2H。2.57 (6H, s), 3.90 (2H, s), 4.2
0 (2H.
02−C6−(4−アセチル−1−ピペラジニル)−2
−(2,4−ジフルオロフェニルアミノ)−5−フルオ
ロニコチノイル〕酢酸エチルニスチル
融点;160〜161’C:(再結溶媒;ベンゼン)I
R(KB r )c@−” rνc=o 1730
,164ONMR(CDCIs )δ値;
1.28(3H,t、J=7Hz)、 2.12(3
H,s)。02-C6-(4-acetyl-1-piperazinyl)-2
-(2,4-difluorophenylamino)-5-fluoronicotinoyl]ethylnistylacetate melting point; 160-161'C: (reconsolidation solvent; benzene) I
R(KB r )c@-” rνc=o 1730
, 164ONMR (CDCIs) δ value; 1.28 (3H, t, J=7Hz), 2.12 (3
H,s).
3.38〜3.97(IOH,m)、 4.22(2
H,q。3.38-3.97 (IOH, m), 4.22 (2
H,q.
J=7Hz)、 6.67〜7.20(2H,m)。J=7Hz), 6.67-7.20 (2H, m).
7.57(IH−dtJ=14Hz)、 7.77〜8
.20(IH,m)、 10.98(IH,ba)0
2−[6−(3−アセチルアミノ−1−ピロリジニル
)−2−(2,4−ジフルオロフェニル7ミ/)−5−
フルオロニコチノイル〕酢酸エチルエステル
融点; 184〜185°C(再結溶媒;酢酸エチル:
エタノール=11)
I R(K B r ) crn−” ;νc=o
1735,167ONMR(CDOla )δ値;
1.27 (3H,t 、 J”7Hz ) 。7.57 (IH-dtJ=14Hz), 7.77~8
.. 20 (IH, m), 10.98 (IH, ba) 0
2-[6-(3-acetylamino-1-pyrrolidinyl)-2-(2,4-difluorophenyl 7mi/)-5-
Fluoronicotinoyl]ethyl acetate ester melting point; 184-185°C (reconsolidation solvent; ethyl acetate:
Ethanol = 11) I R (K B r ) crn-”; νc = o
1735,167 ONMR (CDOla) δ value; 1.27 (3H,t, J"7Hz).
11.25(IH,bs)
実施例3
fi+ 2−(2,4−ジフルオロフェニルアミノ)
−5−フルオロ−6−メドキシニコチンeo、28tを
塩化メチレン3−に懸濁させ、室温で塩化チオニル0.
58FおよびN、N−ジメチルホルムアミド1滴を加え
、加熱還流下で2時間反応させる。減圧下に溶媒νよび
過剰の塩化チオニルを留去し、得られた結晶性物質を塩
イとメチレン6atlK溶解させる。11.25 (IH, bs) Example 3 fi+ 2-(2,4-difluorophenylamino)
-5-Fluoro-6-medoxynicotine eo, 28t, was suspended in methylene chloride 3- and 0.0% thionyl chloride at room temperature.
Add 1 drop of 58F and N,N-dimethylformamide and react under heating under reflux for 2 hours. The solvent ν and excess thionyl chloride are distilled off under reduced pressure, and the obtained crystalline material is dissolved in chloride and methylene 6atlK.
(21シフェニルメチルーエチルーマロナ−1−0,5
91を無水テトラヒドロフラン6 mlに溶解させ。(21cyphenylmethyl-ethylmalona-1-0,5
91 was dissolved in 6 ml of anhydrous tetrahydrofuran.
−20℃で水素什ナトリウム(純度750%)0、09
9を添加し、0〜10℃で1時間反応させる。ついで、
反応液を−20’Cに冷却し、同温度で(1)で得られ
た塩化メチレン溶液を滴下した後、−20〜−10℃で
30分間反応させる。反応液に酢酸0.125’?加え
、減圧下に溶媒を留去し、得られた残留物に酢酸エチル
20m7!および水10IntTh加え、2N−塩酸で
pH2,0に調整する。有機層を分取し、水10−およ
び飽和食塩水lodで順次洗浄した後、蕪水a酸マグネ
シウムで乾燥させる。減圧下に溶媒を留去し。Sodium hydrogen (purity 750%) 0.09 at -20℃
9 is added and reacted at 0 to 10°C for 1 hour. Then,
The reaction solution is cooled to -20'C, and the methylene chloride solution obtained in (1) is added dropwise at the same temperature, followed by reaction at -20 to -10C for 30 minutes. 0.125' of acetic acid in the reaction solution? The solvent was distilled off under reduced pressure, and 20 m7 of ethyl acetate was added to the resulting residue. and 10 IntTh of water were added, and the pH was adjusted to 2.0 with 2N-hydrochloric acid. The organic layer is separated, sequentially washed with water and saturated brine, and then dried over magnesium acetate. The solvent was distilled off under reduced pressure.
得られた残留物にジイソプロピルエーテル5rnlを加
え結晶を戸数すれば、ジフェニルメチル−エチル=2−
(2,4−ジフルオロフェニルアミノ)−5−フルオロ
−6−メドキシニコチノイルマロナー)0.43r(収
率79,2チ)を得る。これをベンゼン−n−ヘキサン
(容量比10 : 1)混合溶媒で再結晶して融点13
0〜131 ’Cを示す結晶を得る。Add 5 rnl of diisopropyl ether to the resulting residue and crystallize it to form diphenylmethyl-ethyl=2-
(2,4-difluorophenylamino)-5-fluoro-6-medoxynicotinoyl malonor) 0.43r (yield 79.2t) is obtained. This was recrystallized from a mixed solvent of benzene-n-hexane (volume ratio 10:1) to a melting point of 13.
Crystals exhibiting 0-131'C are obtained.
I R(KB r )”L−” ;シc=01740.
1730(ah)NMR(CDCl2)δ値;
1.24(3H,t、J=7H2) 、 3.94(
3H,s) 。IR(KBr)"L-"; c=01740.
1730 (ah) NMR (CDCl2) δ value; 1.24 (3H, t, J = 7H2), 3.94 (
3H,s).
4.28(2H,q、J=7Hz)、 5.14(I
H,s)。4.28 (2H, q, J=7Hz), 5.14 (I
H,s).
6.40〜7.64(14H,m)、 7.7C)〜
8.204l−
(IH,m)、 11.10(11(、bs)(3
) ジフェニルメチル−エチル−2−(2,4−ジフ
ルオロフェニルアミノ)−5−フルオロ−6−メドキシ
ニコチノイルマロナー)0.2Orをアニソール2ゴに
溶解させ、水冷下でトリフルオロ酢酸2dを加え、同温
度で10分間反応さ取すれば、2−C2−C2,4−ジ
フルオロフェニルアミノ)−5−フルオo−5−メトキ
シニコチノイル〕酢酸エチルエステル0.129(収率
94.3係)f得る。6.40~7.64 (14H, m), 7.7C)~
8.204l- (IH,m), 11.10(11(,bs)(3
) Diphenylmethyl-ethyl-2-(2,4-difluorophenylamino)-5-fluoro-6-medoxynicotinoyl malonor) 0.2Or was dissolved in anisole 2g, and trifluoroacetic acid 2d was added under water cooling. In addition, if the reaction was carried out for 10 minutes at the same temperature, 2-C2-C2,4-difluorophenylamino)-5-fluoro-5-methoxynicotinoyl]acetic acid ethyl ester 0.129 (yield 94.3%) was obtained. ) get f.
この化合物の物性は実施例2で得られたものと一致した
。The physical properties of this compound were consistent with those obtained in Example 2.
実施例4
2−[2−(2,4−ジフルオロフェニルアミノ)−5
−フルオロ−6−ヒドロキシニコチノイル〕酢酸エチル
エステルo、1ofi酢酸エチル21nt[溶解させ、
氷冷下でジアゾメタン0.015fを含むジエチルニー
デル溶液を添加した後、室温で30分間反応させる。つ
いで1反応液に発泡が生じなくなるまで酢酸を加えた後
、減圧下に溶媒を留去する。得られた結晶性物質にジイ
ソプロピルエーテル2dを加えて結晶を戸数すれば、2
−[2−(2,4−ジフルオロフェニルアミノ)−5−
フルオロ−6−メドキシニコチノイル〕酢酸エチルエス
テル0.08?(収率77.0係)を得る。Example 4 2-[2-(2,4-difluorophenylamino)-5
-Fluoro-6-hydroxynicotinoyl]acetic acid ethyl ester o, 1ofi ethyl acetate 21nt [dissolved,
After adding a diethyl needle solution containing 0.015 f of diazomethane under ice cooling, the mixture is allowed to react at room temperature for 30 minutes. Next, acetic acid was added to the first reaction solution until foaming ceased, and the solvent was distilled off under reduced pressure. Adding 2d of diisopropyl ether to the obtained crystalline substance and dividing the number of crystals gives 2
-[2-(2,4-difluorophenylamino)-5-
Fluoro-6-medoxynicotinoyl]acetic acid ethyl ester 0.08? (yield: 77.0%).
この仕合物の物性は実施例2で得られたものと一致した
。The physical properties of this mixture were consistent with those obtained in Example 2.
実施例5
2−[2−(2,4−ジフルオロフェニル7ミ/)−5
−フルオロ−6−ヒドロキシニコチノイル〕酢酸エチル
エステル0.40SF’e塩イヒメチレン4−に溶解さ
せ、水冷下で2.4.6−)リメチルベンゼンスルホニ
ルクロリド0.30fおよびトリエチルアミン0.15
rを加え、室温で2時間反応させる。Example 5 2-[2-(2,4-difluorophenyl 7mi/)-5
-Fluoro-6-hydroxynicotinoyl]acetic acid ethyl ester 0.40SF'e salt dissolved in ichmethylene 4- and cooled with water 2.4.6-)limethylbenzenesulfonyl chloride 0.30f and triethylamine 0.15
Add r and allow to react at room temperature for 2 hours.
゛りいで1反応液に塩化メチレン4ゴおよび水4dを加
え、有機層全分取し、水4−および飽和食塩水4dで順
次洗浄した後、無水硫酸マグネシウムで乾燥させる。減
圧下に溶媒を留去し、得られた結晶性物質にジエチルエ
ーテル2ゴを加えて結晶を戸数すれば、2−[2−(2
,4−ジフルオロフェニルアミノ)−5−フルオロ−6
−(2,4,6−ドリメチルベンゼンスルホニルオキシ
)ニコチノイル〕酢酸エチルエステル0.52F(収率
85.8チ)を得る。After washing, add 4 g of methylene chloride and 4 d of water to the reaction mixture, separate the entire organic layer, wash sequentially with 4 d of water and 4 d of saturated brine, and then dry over anhydrous magnesium sulfate. The solvent is distilled off under reduced pressure, and diethyl ether 2 is added to the obtained crystalline substance to obtain crystals, resulting in 2-[2-(2
,4-difluorophenylamino)-5-fluoro-6
-(2,4,6-drimethylbenzenesulfonyloxy)nicotinoyl]acetic acid ethyl ester 0.52F (yield: 85.8%) is obtained.
この化合物の物性は実施例2で得られたものと一致した
。The physical properties of this compound were consistent with those obtained in Example 2.
同様にして、つさ゛の化合物を得る。In the same manner, a compound of Tsusa is obtained.
02−[2−(2,4−ジフルオロフェニルアミノ)−
5−フルオロ−6−メタンスルホニルオキシニコチノイ
ル〕酢酸エチルエステル融点;98〜99℃(再結浴媒
;ベンゼン)I R(KB r )(1−” ;シc:
0173ONMR(CDCIa )δ値;
1.27(3H,t、J=7Hz)、 3.28(3
H,s)。02-[2-(2,4-difluorophenylamino)-
5-Fluoro-6-methanesulfonyloxynicotinoyl]acetic acid ethyl ester melting point: 98-99°C (reconsolidation bath medium: benzene) I R (KB r ) (1-”; c:
0173ONMR (CDCIa) δ value; 1.27 (3H, t, J = 7Hz), 3.28 (3
H,s).
3.93(2H,s)、 4.23(2H,q、J=
7Hz)。3.93 (2H, s), 4.23 (2H, q, J=
7Hz).
6.63〜7.43 (2H,m ) 。6.63-7.43 (2H, m).
実施例6
2−〔6−クロロ−2−(2,4−ジフルオロフェニル
アミノ)−5−フルオロニコチノイル〕酢酸エチルエス
テル0. l 5 y k L>J 、 N−ジメチル
ホ ゛ルムアミド1.5mtiC溶解させ、チオ
フェノール0゜072およびトリエチルアミン0.06
fを添加し、室温で1時間反応させる。ついで、反応液
に酢酸エチル20mおよび水Low/を加え、2N−4
酸でpH2,0に調整する。有機層を分取し、水10−
および飽和食塩水10rntでIiM次洗浄した後、無
水硫酸マグネシウムで乾燥させる。減圧下に溶媒全留去
し、得られた結晶性物質にn−ヘキサン5dを加えて結
晶を戸数すれば、2−[2−(2,4−ジフルオロフェ
ニルアミノ)−5−フルオ。−6−フェニルチオニコチ
ノイル〕酢酸エチルエステル0.17r(収率94.6
LI))を得る。Example 6 2-[6-chloro-2-(2,4-difluorophenylamino)-5-fluoronicotinoyl]acetic acid ethyl ester 0. l 5 y k L>J, N-dimethylformamide 1.5mtiC dissolved, thiophenol 0°072 and triethylamine 0.06
Add f and react at room temperature for 1 hour. Next, 20 m of ethyl acetate and water Low/ were added to the reaction solution, and 2N-4
Adjust the pH to 2.0 with acid. Separate the organic layer and add 10-
After washing with IiM and 10rnt of saturated saline, it is dried over anhydrous magnesium sulfate. The solvent was completely distilled off under reduced pressure, and 5d of n-hexane was added to the obtained crystalline substance to form crystals, yielding 2-[2-(2,4-difluorophenylamino)-5-fluoro. -6-phenylthionicotinoyl]acetic acid ethyl ester 0.17r (yield 94.6
LI)) is obtained.
この化合物の物性は実施例2で得られたものと一致した
。The physical properties of this compound were consistent with those obtained in Example 2.
実施例7
.2−[2−(2,4−ジフルオロフェニルアミン)−
5−フルオロ−6−(2,4,6−)リメチルベンゼン
スルホニルオキシ)ニコチノイル]ff+[エチルエス
テルO,’l OreN 、 N−ジメチルホルムアミ
ド1rrLl!に射解させ、エタンチオール0.017
fおよびトリエチルアミン0.021’l’i添加し
、室温で4時間反応させる。ついで、反応液を酢酸エチ
ル3dおよび水3ゴの混合液に加え%2N−4酸でpH
1,0に調整する。有機層を分取し、水2dおよび飽和
食塩水2dで順次洗浄した後、無水硫酸マグネシウムで
乾燥させる。減圧下に溶媒を留去し、得られた残留物を
カラムクロマトグラフィー〔和光シリカゲルC−200
、溶出溶媒;ベンゼン:ヘキサン(容−H比に2)]で
精製すれば、2−[2−(2,4−ジフルオロフェニル
アミノ)−〇−エチルチオー5−フルオロニコチノイル
〕酢酸エチルエステル0.05y(収率67.4係)を
得る。Example 7. 2-[2-(2,4-difluorophenylamine)-
5-Fluoro-6-(2,4,6-)limethylbenzenesulfonyloxy)nicotinoyl]ff+[ethyl ester O,'l OreN, N-dimethylformamide 1rrLl! and ethanethiol 0.017
f and 0.021'l'i of triethylamine are added and allowed to react at room temperature for 4 hours. Then, the reaction solution was added to a mixture of ethyl acetate and water, and the pH was adjusted with %2N-4 acid.
Adjust to 1,0. The organic layer is separated, sequentially washed with 2 d of water and 2 d of saturated brine, and then dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and the resulting residue was subjected to column chromatography [Wako Silica Gel C-200
, elution solvent; benzene:hexane (volume-H ratio: 2)] to obtain ethyl 2-[2-(2,4-difluorophenylamino)-〇-ethylthio-5-fluoronicotinoyl]acetic acid ethyl ester. 05y (yield 67.4%) was obtained.
この化合物の物性は、実施例2で得られたものと一致し
た。The physical properties of this compound were consistent with those obtained in Example 2.
実施例8
2−〔6−クロロ−2−(2,4−ジフルオロフェニル
アミノ)−5−フルオロニコチノイル〕酢酸エチルエス
テルo、sorをクロロホルム5mi!に溶解すせ、3
−アミノピロリジンの二塩酸塩0.261およびトリエ
チルアミン0.5Orを添加し、加熱還流下で1.5時
間反応させる。ついで、反応液をクロロホルム5ゴおよ
び水5tntの混合液に加え、有機層を分取し、水5d
および飽和食塩水5mlで順次洗浄した後、無水硫酸マ
グネシウムで乾燥させる。減圧下に溶媒を留去し、得ら
れた結晶性物質にジイソプロピルエーテル2づを加えて
結晶全戸数すれは、融点140〜142℃を示す2−[
6−(3−アミノ−1−ピロリジニル)−2−(2,4
−ジフルオロフェニルアミノ)−5−フルオロニコチノ
イル〕酢酸エチルエステルo、4sr(収率84.7係
)fjc得る。Example 8 2-[6-chloro-2-(2,4-difluorophenylamino)-5-fluoronicotinoyl]acetic acid ethyl ester o, sor was dissolved in chloroform 5mi! Dissolve in 3
- Add 0.261 l of dihydrochloride of aminopyrrolidine and 0.5 Or of triethylamine, and react under heating under reflux for 1.5 hours. Next, the reaction solution was added to a mixture of 5 d of chloroform and 5 t of water, the organic layer was separated, and 5 d of water was added.
and 5 ml of saturated saline, and then dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and 2 portions of diisopropyl ether were added to the obtained crystalline material to give 2-[
6-(3-amino-1-pyrrolidinyl)-2-(2,4
-difluorophenylamino)-5-fluoronicotinoyl]acetic acid ethyl ester o, 4sr (yield 84.7%) fjc was obtained.
IR(KBr)、−@−1iνc=o 173ONMR
(DMSO−d6 )δ値;
1.22(3H,t、J=7Hz)、 1.50〜2
.30(2H,m)。IR(KBr), -@-1iνc=o 173ONMR
(DMSO-d6) δ value; 1.22 (3H, t, J=7Hz), 1.50-2
.. 30 (2H, m).
3.30〜4.40(9H,m)、 6.RO〜7.
60(2H,m)。3.30-4.40 (9H, m), 6. RO~7.
60 (2H, m).
7.81(IH,d、J=14Hz)、 8.00〜
8.70(IH,m)。7.81 (IH, d, J=14Hz), 8.00~
8.70 (IH, m).
11.45 (IH,bs )
実施例9
無水ピペラジンO,l 4 fをエタノール1.5−に
溶解させ、2−〔6−クロロ−2−(2,4−ジフルオ
ロフェニルアミノ)−5−フルオロニコチノイル〕酢酸
エチルエステル0.15fを分割添加し。11.45 (IH, bs) Example 9 Anhydrous piperazine O,l4f was dissolved in ethanol 1.5- and 2-[6-chloro-2-(2,4-difluorophenylamino)-5-fluoro 0.15 f of ethyl nicotinoyl acetate was added in portions.
室温で30分間反応させる。ついで1反応液をクロロホ
ルム5−および水5dの混合液に加え、有機層を分取し
、水3ゴおよび飽和食塩水3ゴで順次洗浄した後、無水
硫酸マグネシウムで乾燥させる。減圧下に溶媒を留去し
、得られた結晶性物質にn−ヘキサン2ゴ全加えて結晶
を戸数すれば、2−[2−(2,4−ジフルオロフェニ
ルアミノ)−5−フルオロ−6−(1−ピペラジニル)
ニコチノイル〕酢酸エチルエステル0.07t(収率4
1.2%)を得る。これを酢酸エチル−n−ヘキサン(
容量比1(Ml)混合溶媒で再結晶して融点121〜1
23℃を示す結晶を得る。Let react for 30 minutes at room temperature. Next, 1 reaction solution is added to a mixed solution of 5 d of chloroform and 5 d of water, and the organic layer is separated, washed successively with 3 d of water and 3 d of saturated saline, and then dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and 2 g of n-hexane was added to the obtained crystalline substance to form a crystal. -(1-piperazinyl)
Nicotinoyl]acetic acid ethyl ester 0.07t (yield 4
1.2%). This was mixed with ethyl acetate-n-hexane (
Recrystallize with a volume ratio of 1 (Ml) mixed solvent to obtain a melting point of 121-1
Crystals exhibiting a temperature of 23°C are obtained.
IR(KBr)、77、.1ニジc =o 1745.
1730(ah)NMR(CDC1a )δ値;
1.30(3H,t、J=7Hz)、 2.76〜3
.10(4H,m)。IR (KBr), 77,. 1 Niji c = o 1745.
1730 (ah) NMR (CDC1a) δ value; 1.30 (3H, t, J = 7Hz), 2.76-3
.. 10 (4H, m).
3.55〜4.00(6H,m)、 4.21(2H
,q、J”’7Hz)。3.55-4.00 (6H, m), 4.21 (2H
, q, J"'7Hz).
6.40〜7.20 (2H,m)、7.47(IH,
d、J=14Hz)。6.40-7.20 (2H, m), 7.47 (IH,
d, J=14Hz).
7.75〜8.35(IH,m)、 11.10(I
H,bs)実施例10
3−アミノピロリジンの二塩酸塩0.05f全クロロホ
ルム1.5艷に懸濁させ、トリエチルアミン0、11
Fを加え、室温で10分間反応させた後、2−[2−(
2,4−ジフルオロフェニルアミノ)−5−フルオロ−
6−(2,4,6−ドリメチルベンゼンスルホニルオキ
シ)ニコチノイル〕酢酸エチルエステル0.1!Mを加
え、室温で1.5時間反応させる。ついで、反応液にク
ロロホルム5ゴおよび水5111tを加え、有機層を分
取し、水5−および飽和食塩水5mgで順次洗浄した後
、無水硫酸マグネシウムで乾燥させる。減圧下に溶媒を
留去し、得られた結晶性物質にジイソプロピルエーテル
2ゴを加えて結晶を戸取すれば、2−[6−(3−アミ
ノ−1−ピロリジニル)−2−(2,4−ジフルオロフ
ェニルアミノ)−5−フルオロニコチノイル〕酢酸エチ
ルエステル0.11 ? (収率93.2係)を得る。7.75-8.35 (IH, m), 11.10 (I
H, bs) Example 10 3-aminopyrrolidine dihydrochloride 0.05f suspended in 1.5 g of total chloroform, triethylamine 0,11
After adding F and reacting at room temperature for 10 minutes, 2-[2-(
2,4-difluorophenylamino)-5-fluoro-
6-(2,4,6-drimethylbenzenesulfonyloxy)nicotinoyl]acetic acid ethyl ester 0.1! Add M and allow to react at room temperature for 1.5 hours. Next, 5 mg of chloroform and 5111 tons of water are added to the reaction solution, and the organic layer is separated, washed successively with 5 mg of water and 5 mg of saturated saline, and then dried over anhydrous magnesium sulfate. The solvent is distilled off under reduced pressure, diisopropyl ether 2 is added to the obtained crystalline substance, and the crystals are collected to obtain 2-[6-(3-amino-1-pyrrolidinyl)-2-(2, 4-difluorophenylamino)-5-fluoronicotinoyl]acetic acid ethyl ester 0.11 ? (yield: 93.2).
この化合物の物性は実施例8で得られたものと“一致し
た。The physical properties of this compound were "in agreement" with those obtained in Example 8.
実施例11
無水ピペラジン0.13fを塩什メチレン2−に溶解さ
せ、水冷下で2−[2−(2,4−ジフルオ 。Example 11 0.13f of anhydrous piperazine was dissolved in dichloromethane 2-[2-(2,4-difluoro)] under water cooling.
ロフェニルアミノ)−5−フルオロ−6−(2,4゜6
−ドリメチルベンゼンスルホニルオキシ)ニコチノイル
]酢酸エチルエステル0.2Ofを添加し。lophenylamino)-5-fluoro-6-(2,4゜6
-drimethylbenzenesulfonyloxy)nicotinoyl]acetic acid ethyl ester 0.2Of was added.
同温度で40分間反応させる。ついで、反応液を酢酸エ
チルlQdおよび水10dの混合液に加え、有機層を分
取し、飽和炭酸水素す) IJウム水溶液2−および飽
和食塩水2dで順次洗浄した後、無水硫酸マグネシウム
で乾燥させる。減圧下に溶媒を留去し、得られた結晶性
物質にn−ヘキサン1−を加えて結晶を戸数すれば、2
−C2−(2,4−ジフルオロフェニルアミ/ )−5
−フルオロ−6−(1−ピペラジニル)ニコチノイル]
酢酸エチルエステル0.11?(収率69.9%)を得
る。React at the same temperature for 40 minutes. Then, the reaction solution was added to a mixture of 1Qd of ethyl acetate and 10d of water, and the organic layer was separated and washed with 2d of saturated hydrogen carbonate solution and 2d of saturated brine, and then dried over anhydrous magnesium sulfate. let The solvent is distilled off under reduced pressure, and n-hexane 1- is added to the obtained crystalline substance to form a crystal.
-C2-(2,4-difluorophenylami/ )-5
-Fluoro-6-(1-piperazinyl)nicotinoyl]
Ethyl acetate 0.11? (yield 69.9%).
この化合物の物性は実施例9で得られたものと一致した
。The physical properties of this compound were consistent with those obtained in Example 9.
実施例12
2−[6−(3−アミノ−1−ピロリジニル)−2−(
2,4−ジフルオロフェニルアミ/ )−5−フルオロ
ニコチノイル〕酢酸エチルエステル0、10 yをクロ
ロホルム1dに溶解させ、無水酢酸o、oMGrを滴下
し、室温で30分間反応させる。Example 12 2-[6-(3-amino-1-pyrrolidinyl)-2-(
2,4-Difluorophenylami/)-5-fluoronicotinoyl]acetic acid ethyl ester 0,10y is dissolved in chloroform 1d, acetic anhydride o, oMGr are added dropwise, and the mixture is allowed to react at room temperature for 30 minutes.
ついで1反応液を水1ゴおよびクロロホルム1−の混合
液に加え、有機層を分取し、水1−および飽和食塩水1
−で順次洗浄した後、無水硫酸マグネシウムで乾燥させ
る。減圧下に溶媒を留去し。Next, 1 reaction solution was added to a mixture of water 1 and chloroform, the organic layer was separated, and water 1 and saturated saline were added.
- and then dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure.
得られた結晶性物質にジイノブロビルエーテル0.5−
を加えて結晶を戸数すれば、2−[6−(3−アセチル
アミノ−1−ピロリジニル)−2−(2,4−ジフルオ
ロフェニルアミノ)−5−フルオロニコチノイル]酢酸
エチルエステル0.08f(収率72.8係)を得る。Diinobrobyl ether 0.5-
If you add and calculate the number of crystals, 0.08 f of 2-[6-(3-acetylamino-1-pyrrolidinyl)-2-(2,4-difluorophenylamino)-5-fluoronicotinoyl]acetic acid ethyl ester ( A yield of 72.8% was obtained.
この化合物の物性は、実施例2で得られたものと一致し
た。The physical properties of this compound were consistent with those obtained in Example 2.
同様にして、つさ゛の化合物を得る。In the same manner, a compound of Tsusa is obtained.
02−[6−(4−アセチル−1−ピペラジニル)−2
−(2,4−ジフルオロフェニルアミノ)−5−フルオ
ロニコチノイル〕酢酸エチルエステル
この化合物の物・性は実施例2で得られたものと一致し
た。02-[6-(4-acetyl-1-piperazinyl)-2
-(2,4-difluorophenylamino)-5-fluoronicotinoyl]acetic acid ethyl ester The properties and properties of this compound were consistent with those obtained in Example 2.
参考例1
(1) β−イミノ−β−フエノキシブロビオン酸エ
チルエステルの塩酸塩50fおよび2.4−ジフルオロ
アニリン27.8 f ′ff″酢酸エチル300In
tに懸濁させ、加熱還流下で2時間反応させる。Reference Example 1 (1) Hydrochloride of β-imino-β-phenoxybrobionic acid ethyl ester 50f and 2,4-difluoroaniline 27.8 f 'ff'' ethyl acetate 300 In
The mixture was suspended in water and reacted under heating and reflux for 2 hours.
析出結晶を戸数し、酢酸エチル200−で2回、洗浄す
れば、融点196〜197°Cを示すN −(2゜4−
ジフルオロフェニル)アミジノ酢酸エチルエステルの塩
酸塩471(収率82.21)を得る。If the precipitated crystals are separated and washed twice with 200°C of ethyl acetate, N-(2°4-
The hydrochloride salt of difluorophenyl) amidinoacetic acid ethyl ester 471 (yield 82.21) is obtained.
IR(KB r )、WL−1;νc=o 173O
NMR(DMSO−da)δ値;
1.26(3H,t、、J−7Hz)、 4.07(
2H,s)。IR(KB r ), WL-1; νc=o 173O
NMR (DMSO-da) δ value; 1.26 (3H, t, J-7Hz), 4.07 (
2H,s).
4.19(2H,q、J=7Hz)、 7.02〜7
.78(3H,m)。4.19 (2H, q, J=7Hz), 7.02~7
.. 78 (3H, m).
9.11(IH,bs)、 10.26(IH,bs
)。9.11 (IH, bs), 10.26 (IH, bs
).
12.28(IH,bll) 同様にして、つぎの化合物を得る。12.28 (IH, bll) Similarly, the following compound is obtained.
ON −(2,4−−)フルオロフェニル)アミジノ酢
酸メチルエステルの塩酸塩
融点;192〜193℃
I R(KB r )crn−” ; ’c=0173
5NMR(DMSO−da)δ値;
3.74(3H,s)、 4.09(2H,s)、
6.91〜7.73(3H,+n)、 9.15(I
H,bs)、 10.31(IH,bs)。ON -(2,4--)fluorophenyl)amidinoacetic acid methyl ester hydrochloride melting point; 192-193°C I R(KB r ) crn-”; 'c=0173
5NMR (DMSO-da) δ value; 3.74 (3H, s), 4.09 (2H, s),
6.91-7.73 (3H, +n), 9.15 (I
H, bs), 10.31 (IH, bs).
12.29(LH,bs)
ON−(4−フルオロフェニル)アミジノ酢酸メチルエ
ステルの塩1!&塩
融点;134〜135°C
I R(KB r )crn−1;シc=o173ON
MR(DMSO−(16)δ値;
3.74(3H,s)、 4.05(2H,s)、
7.01〜7.59(4H,m)、 8.96(IH
,bs)、 10.06(IH,bs)。12.29 (LH, bs) ON-(4-fluorophenyl)amidinoacetic acid methyl ester salt 1! &salt melting point; 134-135°C IR(KB r ) crn-1; c=o173ON
MR (DMSO-(16) δ value; 3.74 (3H, s), 4.05 (2H, s),
7.01-7.59 (4H, m), 8.96 (IH
, bs), 10.06 (IH, bs).
12.26(IH,b8)
(21N−(2,4−ジフルオロフェニル)アミジノ酢
酸メチルエステルの塩酸塩23.Ofを水92ゴおよび
塩什メチレン92a/の混合液に溶解させ、2N−水酸
什ナトリウム水溶液でpH13,0に調整する。ついで
、有機層を分取し、水5〇−および飽和食壌水50−で
順次洗浄し、無水硫酸マグネシウムで乾燥させる。この
溶液にα−ホルミル−α−フルオロ酢酸エチルエステル
のナトリウム塩27.1 rを室温で加え、加熱還流下
で4時間反応させた後、減圧下に溶媒を留去する。得ら
れた残留物に水92ゴおよび酢酸エチル46m1を加え
、析出結晶を戸数する。ついで、得られた結晶を水18
4艷に懸濁させ。12.26 (IH, b8) (21N-(2,4-difluorophenyl)amidinoacetic acid methyl ester hydrochloride 23.Of is dissolved in a mixture of 92g of water and 92a/methylene salt, and 2N-hydroxyl The pH is adjusted to 13.0 with an aqueous sodium chloride solution.Then, the organic layer is separated, washed successively with 50 ml of water and 50 ml of saturated sodium chloride water, and dried over anhydrous magnesium sulfate. After adding 27.1 r of the sodium salt of α-fluoroacetic acid ethyl ester at room temperature and reacting under heating and reflux for 4 hours, the solvent was distilled off under reduced pressure.The resulting residue was mixed with 92 g of water and ethyl acetate. Add 46ml of water and count the precipitated crystals.Then, add 18ml of water to the resulting crystals.
Suspend in 4 vessels.
6N−塩酸でpH1,0に調整した後、析出結晶に水4
6dおよび2−プロパツール4611tを加えて結晶を
戸数すれば、2−(2,4−ジフルオロフェニルアミノ
)−5−フA/ オO−5−ヒドロキシニコチン酸メチ
ルエステル15.Of(収率57.9係)を得る。これ
を酢酸エチルで再結晶して融点222〜223℃を示す
結晶を得る。After adjusting the pH to 1.0 with 6N hydrochloric acid, add 4 ml of water to the precipitated crystals.
6d and 2-propertool 4611t are added to form a few crystals, 2-(2,4-difluorophenylamino)-5-A/O-5-hydroxynicotinic acid methyl ester 15. Of (yield 57.9%) is obtained. This is recrystallized from ethyl acetate to obtain crystals having a melting point of 222-223°C.
IR(KBr)(@−1;νc=o 170ONMR
(TFA−di)δ値;
4.06(3H,s)、 6.71〜7.65(3H
,m)。IR (KBr) (@-1; νc=o 170ONMR
(TFA-di) δ value; 4.06 (3H, s), 6.71 to 7.65 (3H
, m).
8.12(IH,d、J=11Hz)
同様にして、つぎの化合物を得る、
0 5−7)L/オロー2−(4−フルオロフェニルア
ミノ)−6−ヒドロキシニコチン酸メチルエステル
融点;227〜228℃(再結溶媒;酢酸エチル)I
R(K B r ) 備−” ;ν。=0169ONM
R(T FA −dl )δ値;
4.05(3H,s)、 6.89〜7.53(4H
,m)。8.12 (IH, d, J = 11 Hz) Similarly, the following compound is obtained, 0 5-7) L/olor 2-(4-fluorophenylamino)-6-hydroxynicotinic acid methyl ester melting point; 227 ~228°C (reconsolidation solvent: ethyl acetate) I
R(K B r ) ”;ν.=0169ONM
R(TFA-dl) δ value; 4.05 (3H, s), 6.89-7.53 (4H
, m).
8.11(IH,d、J=11Hz)
参考例2
2−(2,4−ジフルオロフェニルアミノ)−5−フル
オロ−6−ヒドロキシニコチン酸メチルエステル0.2
0fftテトラヒドロフラン6dに溶解させ、氷冷下で
ジアゾメタン0.04yを含むジエチルエーテル酸液を
添加した後、室温で30分間反応させる。ついで1反応
液に発泡が生じなくなるまで酢酸を加えた後、減圧下に
溶媒を留去する。8.11 (IH, d, J = 11 Hz) Reference Example 2 2-(2,4-difluorophenylamino)-5-fluoro-6-hydroxynicotinic acid methyl ester 0.2
After dissolving in 6 d of 0fft tetrahydrofuran and adding a diethyl ether acid solution containing 0.04 y of diazomethane under ice cooling, the mixture is allowed to react at room temperature for 30 minutes. Next, acetic acid was added to the first reaction solution until foaming ceased, and the solvent was distilled off under reduced pressure.
得られた結晶性物質に2−プロパツール61nt′f加
えて結晶を戸数すれば、2− (2,4−ジフルオロフ
ェニルアミノ)−5−フルオロ−6−メドキシニコチン
酸メチルエステル0.15 f (収871.6優)を
得る。これを酢酸エチルで再結晶して融点160.5〜
161.5℃を示す結晶を得る。If 61 nt'f of 2-propanol is added to the obtained crystalline substance and the crystals are counted, 0.15 f of 2-(2,4-difluorophenylamino)-5-fluoro-6-medoxynicotinic acid methyl ester is obtained. (yield: 871.6 yen). This was recrystallized from ethyl acetate with a melting point of 160.5~
Crystals exhibiting a temperature of 161.5°C are obtained.
IR(KBr)、、−1;ν(!=0169ONMR(
CDCJa)δ値;
3.89(3H,s>、 3.98(3H,s)、
6.57〜7.08(2H,、m)、 7.81(
IH,d、J=11Hz)。IR(KBr), -1;ν(!=0169ONMR(
CDCJa) δ value; 3.89 (3H, s>, 3.98 (3H, s),
6.57-7.08 (2H,, m), 7.81 (
IH, d, J = 11Hz).
8.10〜8.97(IH,m)、 10.24−(
]、II、bs)参考例3
2−(2,4−ジフルオロフェニルアミン)−5−フル
オロ−6−ヒドロキシニコチン酸メチルエステル9.5
f、五塩仕リン26.59およびオキシ塩仕リン46.
9rの混合物を70〜80℃で4時間反応させる。つい
で1反応液を水285−に徐々に加え、析出する結晶を
〜取した後、水57ゴで洗浄する。得られた結晶をカラ
ムクロマトグラフィー〔和光シリカゲルC−200、溶
出溶媒:トルエン〕で精製すれば、6−クロロ−2−(
2,4−シフ ルオロフェニルアミノ)−5−フルオロ
ニコチン酸メチルエステル3.5 f (収$34.7
4 )を得る。これをジイソプロピルエーテルで再結晶
して融点]、 39.5〜140.5℃を示す結晶を得
る。8.10-8.97 (IH, m), 10.24-(
], II, bs) Reference Example 3 2-(2,4-difluorophenylamine)-5-fluoro-6-hydroxynicotinic acid methyl ester 9.5
f, five salts 26.59 and oxysalts 46.
The mixture of 9r is reacted at 70-80°C for 4 hours. Next, the reaction mixture was gradually added to 285 g of water, and the precipitated crystals were collected and washed with 57 g of water. If the obtained crystals are purified by column chromatography [Wako silica gel C-200, elution solvent: toluene], 6-chloro-2-(
2,4-cyfluorophenylamino)-5-fluoronicotinic acid methyl ester 3.5 f (Yield: $34.7
4) Obtain. This is recrystallized from diisopropyl ether to obtain crystals having a melting point of 39.5 to 140.5°C.
IR(KBr)、、71−” ;シc:oi 695N
MR(CDCla )δ値薯
3.93(3H,a)、 6.61〜7.06(2H
,m)、 7.94(IH,d、J=9Hz)、
8.15〜8.57(H(、m)。IR (KBr), 71-” ;shic:oi 695N
MR (CDCla) δ value 3.93 (3H, a), 6.61 to 7.06 (2H
, m), 7.94 (IH, d, J=9Hz),
8.15-8.57 (H(, m).
10.13(i、I(、bs)
参考例4
2−(2,4−ジフルオロフェニル7ミ/)−s−フル
オロ−6−ヒドロキシニコチン酸メチルエステル0.5
0 ?を塩什メチレン10m1に懸濁させ、2.4.6
−ドリメチルベンゼンヌルホニルクロリド0、441お
よびトリエチルアミン0.22 fを加え、室温で3時
間反応させる。この溶液に水15m1.を加え、有機層
を分取し、水15ゴで洗浄した後、無水硫酸マグネシウ
ムで乾燥させる。減圧下に溶媒を留去し、得られた結晶
性物質にジエチルエーテル15dを加えて結晶を戸取す
れば、2− (2゜4−ジフルオロフェニルアミノ)−
5−フルオロ−6−(2,4,6−ドリメチルベンゼン
スルホニルオキシ)ニコチン酸メチルエステル0.66
f(収率81.9係)を得る。これを酢酸エチルで再結
晶して融点155〜156℃を示す結晶を得る。10.13(i, I(, bs) Reference Example 4 2-(2,4-difluorophenyl 7mi/)-s-fluoro-6-hydroxynicotinic acid methyl ester 0.5
0? Suspend it in 10 ml of methylene chloride, 2.4.6
Add 0,441 f of -drimethylbenzene sulfonyl chloride and 0.22 f of triethylamine, and react at room temperature for 3 hours. Add 15 ml of water to this solution. The organic layer was separated, washed with 15 g of water, and then dried over anhydrous magnesium sulfate. The solvent is distilled off under reduced pressure, 15d of diethyl ether is added to the obtained crystalline substance, and the crystals are collected to give 2-(2゜4-difluorophenylamino)-
5-Fluoro-6-(2,4,6-drimethylbenzenesulfonyloxy)nicotinic acid methyl ester 0.66
f (yield: 81.9). This is recrystallized from ethyl acetate to obtain crystals having a melting point of 155-156°C.
I R(KB r )(Hm−” r I′c==6
170ONMR(CI)Cla )δ値;
2.33(3H,s)、 2.59(6H,s)、
3.92(3H,s)。I R(KB r )(Hm-" r I'c==6
170ONMR (CI)Cla) δ value; 2.33 (3H, s), 2.59 (6H, s),
3.92 (3H, s).
6.32〜6.84(2H,m)、 6.92(2H
,s)、 7.35〜7.94(IH,m)、 8.
05(IH,d、J=9Hz)。6.32-6.84 (2H, m), 6.92 (2H
, s), 7.35-7.94 (IH, m), 8.
05 (IH, d, J=9Hz).
10.17(IH,bs)
参考例5
6−クロ0−2−(2,4−ジフルオロフェニルアミン
)−5−フルオロニコチン酸メチルエステルo、toy
をN、N−ジメチルホルムアミド7rnlに懸濁させ、
室温でトリエチルアミン0.34fおヨヒエタンチオー
ル0.211を添加し、50℃で4時間反応させる。つ
いで、反応液に酢酸エチル40−≧よび水30ゴを加え
、2N−塩酸でpH2,0に調整する。有機層を分取し
、水20m1および飽和食塩水20−で順次洗浄した後
、無水硫酸マグネシウムで乾燥させる。減圧下に溶媒を
留去し、得られた結晶性物質にn−ヘキサン10−を加
えて結晶を戸数すれば、6−エチルチオー2−(2,4
−ジフルオロフェニルアミノ)−5−フルオロニコチン
酸メチルエステルQ、62y(収率81.9%)を得る
。これをジイソプロピルエーテルで再結晶して融A、1
13.5〜114℃を示す結晶を得る。10.17 (IH, bs) Reference Example 5 6-chloro0-2-(2,4-difluorophenylamine)-5-fluoronicotinic acid methyl ester o, toy
suspended in 7rnl of N,N-dimethylformamide,
Add 0.34 f of triethylamine and 0.211 f of yohyethanethiol at room temperature, and react at 50° C. for 4 hours. Then, 40≧≧40≧ ethyl acetate and 30≧water are added to the reaction solution, and the pH is adjusted to 2.0 with 2N hydrochloric acid. The organic layer is separated, sequentially washed with 20 ml of water and 20 ml of saturated brine, and then dried over anhydrous magnesium sulfate. The solvent is distilled off under reduced pressure, and n-hexane 10- is added to the obtained crystalline substance to obtain crystals, resulting in 6-ethylthio 2-(2,4
-difluorophenylamino)-5-fluoronicotinic acid methyl ester Q, 62y (yield 81.9%) is obtained. This was recrystallized from diisopropyl ether and melted A, 1
Crystals exhibiting a temperature of 13.5-114°C are obtained.
I R(KB r )譚−1; ’c==+) 168
ONMR(CDCla )δ値;
1.29(3H,t、J=7Hz)、3.07(2H,
(1,J=7Hz)。I R (KB r ) Tan-1; 'c==+) 168
ONMR (CDCla) δ value; 1.29 (3H, t, J=7Hz), 3.07 (2H,
(1, J=7Hz).
3.90(3H,s) 、 6.50〜7.20(2
H,m) 、 7.66(IH。3.90 (3H, s), 6.50-7.20 (2
H, m), 7.66 (IH.
d、J”l0I(z)、 7.80〜8.50(II
(、m)、 io、00(LH,s)
同様にして、つき゛の化合物を得る。d, J"l0I(z), 7.80~8.50(II
(, m), io, 00 (LH, s) In the same manner, the compound with ゛ is obtained.
02−(2,4−ジフルオロフェニルアミノ)−5−フ
ルオロ−6−フェニルチオニコチン酸メチルエステル
融点;128〜J285°C(再結溶媒;ジイソプロピ
ルエーテル)IR(/(Br )、fn−1;シc−=
o 1685NMf尤(CI)C13’)δ値;
10.25(IH,bs )
参考例6
3−アミノピロリジンの二塩酸場0.121をN。02-(2,4-difluorophenylamino)-5-fluoro-6-phenylthionicotinic acid methyl ester melting point; 128-J285°C (reconsolidation solvent; diisopropyl ether) IR (/(Br), fn-1; C-=
o 1685NMf (CI) C13') δ value; 10.25 (IH, bs) Reference Example 6 Dihydrochloric acid field of 3-aminopyrrolidine 0.121N.
N−ジメチルホルムアミド3ゴに懸濁させ、トリエチル
アミン0.259を加え、室温で5分間反応させた後、
2−(2,4−ジフルオロフェニルアミノ)−5−フル
オロ−6−(2,4,、6−ドリメチルベンゼンスルホ
ニルオキシ)ニコチン酸メチルエステル0.3 Orを
加え、室温で1.5時間反応させる。反応液にクロロホ
ルム10m1および水10m/を加え、有機層を分取し
、水1.0 dおよび飽和食増水1.0 m/!で順次
洗卵した後、無水硫酸マグネシウムで乾燥させる。つい
で無水酢酸0.1Ofを加え、室温で10分間反応させ
た後、減圧下に溶媒を留去する。得られた結晶性物質に
ジエチルエーテル5dを加え結晶を戸数すれば、6−(
3−アセチルアミノ−1−ピロリジニル)−2−(2,
4−ジフルオロフェニルアミノ)−5−フルオロニコチ
ン酸メチルエステル0.21 y (収率R2,4Uを
得る。こiを酢酸エチルで再結晶して融点202〜20
3℃を示す結晶を得る。After suspending in N-dimethylformamide 3 and adding 0.259% of triethylamine and reacting at room temperature for 5 minutes,
Add 0.3 Or of 2-(2,4-difluorophenylamino)-5-fluoro-6-(2,4,,6-drimethylbenzenesulfonyloxy)nicotinic acid methyl ester and react at room temperature for 1.5 hours. let Add 10 ml of chloroform and 10 m/ml of water to the reaction solution, separate the organic layer, and add 1.0 d/ml of water and 1.0 m/ml of saturated food! After sequentially washing the eggs with water, the eggs are dried with anhydrous magnesium sulfate. Then, 0.1Of acetic anhydride was added and the mixture was allowed to react at room temperature for 10 minutes, and then the solvent was distilled off under reduced pressure. Add diethyl ether 5d to the obtained crystalline substance and count the crystals to obtain 6-(
3-acetylamino-1-pyrrolidinyl)-2-(2,
4-difluorophenylamino)-5-fluoronicotinic acid methyl ester 0.21 y (yield R2.4U was obtained. This i was recrystallized from ethyl acetate to give a melting point of 202-20
Crystals showing a temperature of 3°C are obtained.
IR(KBr)、;@−] ;シc=o1675NMR
(CDC1a−DMSO−d6)δ値:6.63〜7.
1.7(2H,m)、 7.62(LH,d、J=14
Hz)。IR(KBr), ;@-] ;shic=o1675NMR
(CDC1a-DMSO-d6) δ value: 6.63-7.
1.7 (2H, m), 7.62 (LH, d, J=14
Hz).
7.83〜8.60 (2H、m ) 、 10.30
(II(、bs )同様にして、つき゛の化合′吻を
得る。7.83-8.60 (2H, m), 10.30
(II(, bs)) In the same manner, obtain the compound proboscis.
06−(4−アセチル−1−ピペラジニル)−2−(2
,4−ジフルオロフェニルアミノ)−5一フルオロニコ
チン酸メチルエステル
融点;172〜173’C(再結溶媒;酢酸エチル)I
R(KBr )、、−1、νc=o 1680,16
5ONMR(CDC13)δ値;
6.57〜7.07(2H,m)、7.68(IH,d
、J=13Hz)。06-(4-acetyl-1-piperazinyl)-2-(2
, 4-difluorophenylamino)-5-fluoronicotinic acid methyl ester melting point: 172-173'C (reconsolidation solvent: ethyl acetate) I
R(KBr), -1, νc=o 1680,16
5ONMR (CDC13) δ value; 6.57-7.07 (2H, m), 7.68 (IH, d
, J=13Hz).
7.77〜8.18(IH,m)、1.0.05(IH
,bs)参考例7
2−(2,4−ジフルオロフェニルアミノ)−5−フル
オロ−6−ヒドロキシニコチン酸メチルエステル3.0
Ofをメタノール30ゴに懸濁させ、室温で2N−水酸
什ナトリウム水落液16.1ゴを加えた後、加熱還流下
で4時間反応させる。ついで、反応液を酢酸エチル60
−および水60ゴの混合液に加え、水層を分取する。こ
の水層を6N−塩酸でpI(1,0に調整し、析出晶を
戸数した後、水15 meおよび2−プロパツール15
−で順次洗浄tiば、2− (2,4−ジフルオロフェ
ニルアミ/)−5−フルオロ−6−ヒドロキシニコチン
酸2.68f(収率93,7%)を得る。これをアセト
ン−エタノール(容量比1:1)混合溶媒で再結晶して
融点215〜216℃分示す結晶を得る。7.77-8.18 (IH, m), 1.0.05 (IH
, bs) Reference Example 7 2-(2,4-difluorophenylamino)-5-fluoro-6-hydroxynicotinic acid methyl ester 3.0
Of is suspended in 30 g of methanol, 16.1 g of a 2N aqueous solution of sodium hydroxide is added at room temperature, and the mixture is allowed to react under heating under reflux for 4 hours. Then, the reaction solution was diluted with 60% ethyl acetate.
- and 60 g of water, and separate the aqueous layer. This aqueous layer was adjusted to pI (1,0) with 6N-hydrochloric acid, and after removing the precipitated crystals, 15 me of water and 15 of 2-propanol were added.
After sequential washing with -, 2.68f of 2-(2,4-difluorophenylami/)-5-fluoro-6-hydroxynicotinic acid (yield 93.7%) is obtained. This is recrystallized from a mixed solvent of acetone and ethanol (volume ratio 1:1) to obtain crystals having a melting point of 215-216°C.
I R(KB r )crn−1;νc=o1.70
ONMR(DMSO−d6)δ値;
6、fi5〜7.58 (2H,m ) 、 7.8
6 (IH、d 、 J=11Hz )。I R(KB r ) crn-1; νc=o1.70
ONMR (DMSO-d6) δ value; 6, fi5-7.58 (2H,m), 7.8
6 (IH, d, J=11Hz).
8.12〜8.68(IH,m)、 10.49(I
H,bs)同様にして、つざの什合物を得る。8.12-8.68 (IH, m), 10.49 (I
H, bs) In the same manner, obtain a Tsuza mixture.
Q5−フルオロ−2−(4−フルオロフェニルアミノ)
−6−ヒドロキシニコチン酸
融点;216〜217°G(再結溶媒;アセトソ:メタ
ノール=111 )
IR(KBr )g−4;シc−o 1685 (sh
)NMR(DMSO−d6)δ値;
6.84〜7.94(5H,m)、 10.33(I
H,bs)参考例8
2−(2,4−ジフルオロフェニルアミノ)−5−フル
オロ−6−メドキシニコチン酸メチルエステル2.0O
fをテトラヒドロフラン60tnlに溶解させ、室温で
IN−水酸什ナトリウム水溶液25.5#!/を加え、
加熱還流下で7時間反応させる。ついで、減圧下に溶媒
を留去し、得られた残留物に酢酸エチル100II+/
および水100ゴを加え、2N−塩酸でpH2,OK調
整する。有機層を分取し、水50+dおよび飽和食塩水
50−で順次洗浄した後、無水硫酸マグネシウムで乾燥
させる。減圧下に溶媒を留去し、得られた結晶性物質に
ジエチルエーテル10ゴを加えて結晶を渥取すれば、2
−(2,4−ジフルオロフェニルアミノ)−5−フルオ
ロ−6−メドキシニコチン酸1.40t(収率73.3
9G)t’−得る。これをアセトンで再結晶して融点2
39〜240℃を示す結晶を得る。Q5-fluoro-2-(4-fluorophenylamino)
-6-hydroxynicotinic acid melting point; 216-217°G (reconsolidation solvent; acetoso:methanol = 111) IR (KBr) g-4;
) NMR (DMSO-d6) δ value; 6.84-7.94 (5H, m), 10.33 (I
H, bs) Reference Example 8 2-(2,4-difluorophenylamino)-5-fluoro-6-medoxynicotinic acid methyl ester 2.0O
Dissolve f in 60 tnl of tetrahydrofuran and add 25.5# of IN-sodium hydroxide aqueous solution at room temperature. Add /,
The reaction is allowed to proceed under heating under reflux for 7 hours. Then, the solvent was distilled off under reduced pressure, and the resulting residue was diluted with ethyl acetate 100II+/
Add 100 g of water and adjust the pH to 2 with 2N hydrochloric acid. The organic layer is separated, washed sequentially with 50+d of water and 50% of saturated brine, and then dried over anhydrous magnesium sulfate. The solvent is distilled off under reduced pressure, 10 g of diethyl ether is added to the obtained crystalline substance, and the crystals are collected.
-(2,4-difluorophenylamino)-5-fluoro-6-medoxynicotinic acid 1.40t (yield 73.3
9G) t'-obtain. This is recrystallized with acetone and has a melting point of 2.
Crystals exhibiting a temperature of 39-240°C are obtained.
I R(K B r )(Hg−” ;シc=o166
5 ′NMR(DMS O−da)δ値;
3.98(3H,s)、 6.76〜7.48(2H,
m)。I R (K B r ) (Hg-”; c=o166
5′ NMR (DMS O-da) δ value; 3.98 (3H, s), 6.76-7.48 (2H,
m).
7.86(IH,d、J=11Hz)、 8.10〜8
.60(IH,m)。7.86 (IH, d, J=11Hz), 8.10~8
.. 60 (IH, m).
10.51(IH,bs) 同様にして、つざの化合物を得る。10.51 (IH, bs) In the same manner, the compound of Tsuza is obtained.
06−クロロ−2−(2,4−ジフルオロフェニルアミ
ノ)−5−フルオロニコチン酸
融点;226〜2286C(再結溶媒;ベンゼン)I
R(KB r )cm−” iνQ=Q 168ON
MR(アセトン−da)δ値;
6.60〜7.41(2H,m)。06-chloro-2-(2,4-difluorophenylamino)-5-fluoronicotinic acid Melting point: 226-2286C (Recrystallization solvent: Benzene) I
R(KB r ) cm-” iνQ=Q 168ON
MR (acetone-da) δ value: 6.60-7.41 (2H, m).
10.30(IH,bs)、10.64(IH,bS)
0 2−(2,4−ジフルオロフェニルアミノ)−5−
フルオロ−6−(2,4,6−ドリメチルベンゼンスル
ホニルオキシ)ニコチン酸
融点+179〜180℃(再結溶媒;ベンゼン)IR(
KBr)、H@−1;シc=o1665NMR(アセト
ン−da)δ値;
2.32(3H,8)、 2.55(6H,s)。10.30 (IH, bs), 10.64 (IH, bS)
0 2-(2,4-difluorophenylamino)-5-
Fluoro-6-(2,4,6-drimethylbenzenesulfonyloxy)nicotinic acid melting point +179-180°C (reconsolidation solvent; benzene) IR (
KBr), H@-1; c=o1665 NMR (acetone-da) δ value; 2.32 (3H, 8), 2.55 (6H, s).
02−(2,4−ジフルオロフェニルアミノ)−6−エ
チルチオ−5−フルオロニコチン酸融点;209〜21
0°C(再結溶媒;ベンゼン)= 65−
IR(KBr )、、−1ニジc−=o1665NMR
(アセトン−da )δ値;
1.30(3H,t、J−”7Hz)、3.14(2H
,q、J=7Hz)。02-(2,4-difluorophenylamino)-6-ethylthio-5-fluoronicotinic acid Melting point: 209-21
0°C (recrystallization solvent; benzene) = 65-IR (KBr), -1 di-c- = o1665 NMR
(acetone-da) δ value; 1.30 (3H, t, J-”7Hz), 3.14 (2H
, q, J=7Hz).
6.70〜7.50(2H,m)。6.70-7.50 (2H, m).
9.70(IH,bs)、 10.27(IH,bs
)0 2−(2,4−ジフルオロフェニル7ミ/)−5
−フルオロ−6−フェニルチオニコチン酸融点;264
〜265℃(再結溶媒;酢酸エチル:エタノール=1冨
1)
IR(KBr )C@−” Iシc=o166ONMR
(DMSO−da)δ値;
6.00〜7.73(J(H,m)、7.F+5(IH
,d、J=10Hz)。9.70 (IH, bs), 10.27 (IH, bs
)0 2-(2,4-difluorophenyl7mi/)-5
-Fluoro-6-phenylthionicotinic acid Melting point; 264
~265°C (reconsolidation solvent; ethyl acetate: ethanol = 1 concentration 1) IR (KBr)C@-” Ishic=o166ONMR
(DMSO-da) δ value; 6.00 to 7.73 (J(H,m), 7.F+5(IH
, d, J=10Hz).
10.58(IH,bs)
参考例9
6−(3−アセチルアミノ−1−ピロリジニル)−2−
(2,4−ジフルオロフェニルアミノ)−5−フルオロ
ニコチン酸メチルエステル0.981F’t−テトラヒ
ドロフラン30d、メタノールlOdおよび水4dの混
合液に懸濁させ、IN−水酸仕ナトリウム水溶液5.3
1ntを加え、65℃で3時間反応させる。ついで、反
応液を酢酸エチル507!および水50ILtの混合液
に加え、水層を分取した後IN−塩酸でpH2,0に調
整する。析出結晶を炉底し、水2dおよびエタノール2
−で順次洗浄すれば、6−(3−アセチルアミノ−1−
ピロIJ シニル)−2−(2,4−ジフルオロフェニ
ルアミノ)−5−フルオロニコチン酸o、88yc収率
93.0チ)を得る。これをアセトン−メタノール(容
量比1:1)混合溶媒で再結晶して融点233.5〜2
36℃を示す結晶を得る。10.58 (IH, bs) Reference Example 9 6-(3-acetylamino-1-pyrrolidinyl)-2-
(2,4-difluorophenylamino)-5-fluoronicotinic acid methyl ester 0.981 F't-Tetrahydrofuran 30 d, methanol 10 d and water 4 d suspended in a mixture of 5.3 ml of IN-sodium hydroxide aqueous solution
Add 1 nt and react at 65°C for 3 hours. Then, the reaction solution was diluted with ethyl acetate 507! and 50 ILt of water, and after separating the aqueous layer, the pH was adjusted to 2.0 with IN-hydrochloric acid. The precipitated crystals were poured into the bottom of the furnace and mixed with 2 d of water and 2 d of ethanol.
-, 6-(3-acetylamino-1-
PyroIJ (cynyl)-2-(2,4-difluorophenylamino)-5-fluoronicotinic acid o, 88yc, yield 93.0h) is obtained. This was recrystallized from a mixed solvent of acetone-methanol (volume ratio 1:1), with a melting point of 233.5-2.
Crystals exhibiting a temperature of 36°C are obtained.
IR(KBr)、、−1;シc=o1645NMR(T
FA−di )δ値;
6.82〜7.80(3H,m)、 8.27(IH
,d、J=13Hz)同様にして、つき゛の化合物を得
る。IR(KBr), -1; c=o1645NMR(T
FA-di) δ value; 6.82 to 7.80 (3H, m), 8.27 (IH
, d, J=13Hz) In the same manner, the compound with t is obtained.
06−(4−アセチル−1−ピペラジニル)−2−(2
,4−ジフルオロフェニルアミノ)−5−フルオロニコ
チン酸
融点;243〜244℃(再結溶媒;酢酸エチル=エタ
ノール=11)
I R(KB r )z−1;νc=o 1670,1
635(sh)NMR(TFA−dx )δ値;
2.48(3H,s)、 3.47〜4.40(l(
H,m)。06-(4-acetyl-1-piperazinyl)-2-(2
, 4-difluorophenylamino)-5-fluoronicotinic acid Melting point: 243-244°C (reconsolidation solvent: ethyl acetate = ethanol = 11) I R (KB r ) z-1; νc = o 1670,1
635 (sh) NMR (TFA-dx) δ value; 2.48 (3H, s), 3.47-4.40 (l(
H, m).
64(3〜7.R2(3)(、m)、8.47(IH,
d、J=13Hz)参考例10
6−(3−アセチルアミノ−1−ピロリジニル)−2−
(2,4−ジフルオロフェニル7ミ/)−5−フルオロ
ニコチノイル酢酸エチルエステル0o20f’z−ベン
ゼン2−に悉濁させ、 N 、 N−シメfルホルムア
ミドジメチルアセタール0.1Ofを加え、加熱還流下
で7時間反応させる。ついで、析出結晶をP取し、ジエ
チルエーテル2dで洗浄すれば、7−(3−アセチルア
ミノ−1−ピロリジニル)−1−(2,4−ジフルオロ
フェニル)−6−フルオロ−1,4−ジヒドロ−4−オ
キソ−1,8−ナフチリジン−3−カルボン酸エチルエ
ステル0.182(収率88.1係)を得る。これをア
セトン−メタノール(容量比1:1)混合溶媒で再結晶
して融点234〜236℃を示す結晶を得る。64 (3-7.R2(3)(,m), 8.47(IH,
d, J=13Hz) Reference Example 10 6-(3-acetylamino-1-pyrrolidinyl)-2-
(2,4-difluorophenyl 7/)-5-fluoronicotinoyl acetic acid ethyl ester 0o20f'z-Suspension in benzene 2-, add 0.1Of N,N-dimethylformamide dimethyl acetal, and heat under reflux. Let it react for 7 hours at a lower temperature. Then, the precipitated crystals are collected and washed with diethyl ether 2d to give 7-(3-acetylamino-1-pyrrolidinyl)-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro. -4-oxo-1,8-naphthyridine-3-carboxylic acid ethyl ester 0.182 (yield: 88.1) is obtained. This is recrystallized with a mixed solvent of acetone-methanol (volume ratio 1:1) to obtain crystals having a melting point of 234-236°C.
NMR(CDC]a)δ値; 1.33(3H,t 、J=7Hz ) 。NMR (CDC) a) δ value; 1.33 (3H, t, J=7Hz).
参考例11
7−(3−アセチルアミノ−1−ピロリジニル)−1−
(2,4−ジフルオロフェニル)−6−フルオロ−1,
4−ジヒドロ−4−オキソ−1,8−ナフチリジン−3
−カルボン酸エチルエステル0.50fft6N−塩酸
5−に溶解させ、加熱還流下で4時間反応させる。つい
で、析出結晶を戸数し、水1Intで洗浄すれば、7−
(3−アミノ−1−ピロリジニル)−1−(2,4−ジ
フルオロフェニル)−6−フルオロ−1,4−ジヒドロ
−4−オキソ−1゜8−ナフチリジン−3−カルボン酸
の塩酸塩0.39f(収率84.0係)全傅る。これを
#塩酸−エタノール(容量比l:3)混合溶媒で再結晶
して融点247〜250℃(分解)′fr示す結晶を得
る。Reference Example 11 7-(3-acetylamino-1-pyrrolidinyl)-1-
(2,4-difluorophenyl)-6-fluoro-1,
4-dihydro-4-oxo-1,8-naphthyridine-3
-Carboxylic acid ethyl ester (0.50 fft) is dissolved in 6N hydrochloric acid (5-) and reacted under heating under reflux for 4 hours. Then, if the precipitated crystals are separated and washed with 1 int of water, 7-
(3-Amino-1-pyrrolidinyl)-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-1°8-naphthyridine-3-carboxylic acid hydrochloride 0. 39f (yield: 84.0). This is recrystallized from a mixed solvent of #hydrochloric acid and ethanol (volume ratio 1:3) to obtain crystals having a melting point of 247-250°C (decomposed)'fr.
NMR(TFA−di )δ値;
2.23〜2.95(2H,m)、 3.38〜4.
83(5H,m)。NMR (TFA-di) δ value; 2.23-2.95 (2H, m), 3.38-4.
83 (5H, m).
6.95〜7.90(3)i、m)、 8.22(I
H,dIJ=lIHz)e9.18(IH,s)
参考例12
参考例10および11と同様にして、っぎの什合物′f
得る。6.95-7.90 (3) i, m), 8.22 (I
H, dIJ=lIHz)e9.18(IH,s) Reference Example 12 In the same manner as Reference Examples 10 and 11, the mixture 'f
obtain.
0l−(2,4−ジフルオロフェニル)−6−フルオロ
−1,4−ジヒドロ−4−オキソ−7−(1−ピペラジ
ニル)−1,8−ナフチリジン−3−カルボン酸の塩酸
塩
融点;249〜252℃(分解)(再結溶媒;#塩酸:
メタノール=1 : 2 )
NMR(TFA −dx )δ値;
3.33〜3.92(4H,m)、 3.92〜4.
50(4H,m)。0l-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-1,8-naphthyridine-3-carboxylic acid hydrochloride Melting point: 249~ 252℃ (decomposition) (reconsolidation solvent; #hydrochloric acid:
Methanol=1:2) NMR (TFA-dx) δ value; 3.33-3.92 (4H, m), 3.92-4.
50 (4H, m).
6.90〜7.90(3H,m)、8.30(]、H,
d、J=12Hz)。6.90-7.90 (3H, m), 8.30 (], H,
d, J=12Hz).
9.18(IH,5) −71−+−+9.18 (IH, 5) -71-+-+
Claims (1)
ハロゲン原子、ヒドロキシル基、アミノ基が保護されて
いてもよい3−アミノピ ロリジニル基、イミノ基が保護されていて もよいピペラジニル基、置換基を有してい てもよいアルコキシ、アルキルチオ、アリ ールチオ、アルカンスルホニルオキシまた はアレーンスルホニルオキシ基を;および Xは水素原子またはフッ素原子を示す。〕 で表わされる2−(5−フルオロニコチノイル)酢酸誘
導体およびその塩。(1) General formula ▲ Numerical formula, chemical formula, table, etc. ▼ [In the formula, R^1 is a carboxyl protection forming group; R^2 is 3-, which may have a halogen atom, hydroxyl group, or amino group protected. An aminopyrrolidinyl group, a piperazinyl group where the imino group may be protected, an alkoxy, alkylthio, arylthio, alkanesulfonyloxy or arenesulfonyloxy group which may have a substituent; and X is a hydrogen atom or fluorine Indicates an atom. ] A 2-(5-fluoronicotinoyl)acetic acid derivative and a salt thereof.
Priority Applications (50)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP60028397A JPH0629246B2 (en) | 1985-02-18 | 1985-02-18 | 2- (5-fluoronicotinoyl) acetic acid derivative and its salt |
AT72/86A AT392789B (en) | 1985-01-23 | 1986-01-14 | METHOD FOR PRODUCING 1-SUBSTITUTED ARYL-1,4-DIHYDRO-4-OXONAPHTHYRIDINE DERIVATIVES |
GB8601045A GB2170804B (en) | 1985-01-23 | 1986-01-16 | Novel process for producing 1-substituted aryl-1, 4-dihydro-4-oxonaphthyridine derivative, intermediates thereof and processes for producing the intermediates |
US06/819,821 US4704459A (en) | 1985-01-23 | 1986-01-17 | Process for producing 1-substituted aryl-1,4-dihydro-4-oxonaphthyridine derivatives, and processes for producing the intermediates |
FI860250A FI83313C (en) | 1985-01-23 | 1986-01-20 | New process for the preparation of 1- (substituted aryl) -1,4-dihydro-4-oxo-1,8-naphthyridine derivatives and intermediates useful in the process |
DE3637679A DE3637679C1 (en) | 1985-01-23 | 1986-01-20 | 2- (5-fluoronicotinoyl) acetic acid derivatives and process for their preparation |
DE19863601517 DE3601517A1 (en) | 1985-01-23 | 1986-01-20 | NEW METHOD FOR PRODUCING 1-SUBST.-ARYL-1,4-DIHYDRO-4-OXONAPHTHYRIDINE DERIVATIVES, INTERMEDIATE PRODUCTS THEREOF AND METHOD FOR PRODUCING THE INTERIM PRODUCTS |
DE3641633A DE3641633C2 (en) | 1985-01-23 | 1986-01-20 | New 5-fluoronicotinic acid derivatives, their salts and reactive derivatives of the carboxyl group thereof |
AU52543/86A AU576657B2 (en) | 1985-01-23 | 1986-01-21 | Naphthyridine and pyridine derivatives |
BE0/216165A BE904086A (en) | 1985-01-23 | 1986-01-22 | NOVEL PROCESS FOR THE MANUFACTURE OF A DERIVATIVE OF (SUBSTITUTED ARYL) -1 DIHYDRO-1,4 OXO-4 NAPHTYRIDINE INTERMEDIATE SUBSTANCES USED FOR THIS MANUFACTURE AND METHODS OF MANUFACTURE OF INTERMEDIATE SUBSTANCES. |
PH33316A PH22711A (en) | 1985-01-23 | 1986-01-22 | Novel process for producing 1-substituted aryl-1,4-dihydro-4-oxonaphthyridine derivative, intermediates thereof and processes for producing the intermediates |
CH235/86A CH667456A5 (en) | 1985-01-23 | 1986-01-22 | METHOD FOR PRODUCING 1,4-DIHYDRO-4-OXONAPHTHYRIDINE DERIVATIVES CARRYING A SUBSTITUTED ARYL REST IN 1-POSITION. |
ES551134A ES8702362A1 (en) | 1985-01-23 | 1986-01-22 | 1-Fluoro:phenyl-1,8-naphthyridine-3-carboxylic acid derivs. prodn. |
NZ214901A NZ214901A (en) | 1985-01-23 | 1986-01-22 | Naphthyridine derivatives and nicotinic acid derivative intermediates |
NL8600138A NL192986C (en) | 1985-01-23 | 1986-01-22 | Process for preparing 1,4-dihydro-4-oxo-naphthyridine derivatives. |
KR1019860000388A KR880001078B1 (en) | 1985-01-23 | 1986-01-22 | Process for the preparation of 1-substituted arye-1,4-dihydro-4-oxonaphthyridine derivatives |
NO860226A NO163227C (en) | 1985-01-23 | 1986-01-22 | PROCEDURE TE FOR PREPARATION OF 1-SUBSTITUTED-ARYI HYDRO-4-OXONAFTYRIDINE DERIVATIVES. |
CA000500107A CA1340706C (en) | 1985-01-23 | 1986-01-22 | Process for producing 1-substituted aryl-1,4-dihydro-4-oxonaphthyridine derivative, intermediates therefor and processes for producing the intermediates |
FR868600871A FR2576305B1 (en) | 1985-01-23 | 1986-01-22 | NOVEL PROCESS FOR THE MANUFACTURE OF A DERIVATIVE OF (SUBSTITUTED ARYL) -1 DIHYDRO-1,4 OXO-4 NAPHTYRIDINE, INTERMEDIATE SUBSTANCES USED FOR THIS MANUFACTURE AND METHODS OF MANUFACTURE OF INTERMEDIATE SUBSTANCES |
CH643/88A CH671957A5 (en) | 1985-01-23 | 1986-01-22 | |
PT81889A PT81889B (en) | 1985-01-23 | 1986-01-22 | PROCESS FOR THE PREPARATION OF POSITION 1 SUBSTITUTED ARIL-1,4-DIHIDRO-4-OXONETHRIDIDINE DERIVATIVES AND INTERMEDIATE COMPOUNDS USED IN THAT PROCESS |
DK032286A DK169570B1 (en) | 1985-01-23 | 1986-01-22 | Process for the preparation of 1-substituted aryl-1,4-dihydro-4-oxonaphthyridine derivatives |
SE8600274A SE462164B (en) | 1985-01-23 | 1986-01-22 | PROCEDURES FOR PREPARING 1-SUBSTITUTED ARYL-1,4-DIHYDRO-4-OXONAFTYRIDE DERIVATIVES |
IT47562/86A IT1190193B (en) | 1985-01-23 | 1986-01-22 | PROCEDURE FOR THE PRODUCTION OF AN ARIL-1,4-DIHYDRO-4-OSSONAFTYRIDINE 1-SUBSTITUTE DERIVATIVE, INTERMEDIATE FOR THE SAME, AND PROCEDURES FOR THE PRODUCTION OF INTERMEDIATES |
CN 86100879 CN1019012B (en) | 1985-01-23 | 1986-01-22 | Process for producing 1-substituted aryl-1, 4-dihydro-4-oxonaphthyridine derivative intermediates |
LU86264A LU86264A1 (en) | 1985-01-23 | 1986-01-23 | NOVEL PROCESS FOR THE PREPARATION OF A DERIVATIVE OF ARYL-1,4-DIHYDRO 4-OXONAPHTYRIDINE 1-SUBSTITUTED INTERMEDIATE PRODUCTS FOR THIS DERIVATIVE AND PROCESS FOR THE PREPARATION OF INTERMEDIATE PRODUCTS |
IL77688A IL77688A (en) | 1985-01-23 | 1986-01-23 | Process for producing 7-substituted-6-fluoro-1-(4-fluoro or 2,4-difluorophenyl)-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid derivatives and some new such derivatives produced thereby |
IL88468A IL88468A (en) | 1985-01-23 | 1986-01-23 | 2-(4-fluoro or 2,4-difluorophenylamino)-5-fluoro-6-substituted nicotinic acid and nicotinyl acetic acid and their preparation |
IL9240186A IL92401A (en) | 1985-01-23 | 1986-01-23 | Process for producing 7-halogeno-1-(4-fluoro or 2,4-difluorophenyl)-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid derivative |
ES557077A ES8707730A1 (en) | 1985-01-23 | 1986-09-19 | 1-Fluoro:phenyl-1,8-naphthyridine-3-carboxylic acid derivs. prodn. |
ES557078A ES8707715A1 (en) | 1985-01-23 | 1986-09-19 | 1-Fluoro:phenyl-1,8-naphthyridine-3-carboxylic acid derivs. prodn. |
PH35456A PH23202A (en) | 1985-01-23 | 1987-06-25 | 2-(5-fluoronicotinoyl) acetic acid derivatives and process of preparation thereof |
PH35456A PH22956A (en) | 1985-01-23 | 1987-06-25 | Fluoronicotinic avid derivatives and process of preparing said compounds |
US06/067,264 US4851535A (en) | 1985-01-23 | 1987-06-29 | Nicotinic acid derivatives |
CH642/88A CH669378A5 (en) | 1985-01-23 | 1988-01-22 | 1-Fluoro:phenyl-1,8-naphthyridine-3-carboxylic acid derivs. prodn. |
GB8811645A GB2204040B (en) | 1985-01-23 | 1988-05-17 | 2-(5-fluoronicotinoyl)-acetic acid intermediates |
CA 568266 CA1340648C (en) | 1985-01-23 | 1988-05-31 | Process for producing 1-substituted aryl-1, 4-dihydro-4-oxonaphthyridine derivative, intermediates therefor and porcesses for producing the intermediates |
CA000568265A CA1340783C (en) | 1985-01-23 | 1988-05-31 | Process for producing 1-substituted aryl-1, 4-dihydro-4-oxonaphthyridine derivative, intermediates therefor and processes for producing the intermediates |
SE8902265A SE469984B (en) | 1985-01-23 | 1989-06-21 | 5-Fluoronicotinic acid derivative and process for its preparation |
SE8902264A SE469983B (en) | 1985-01-23 | 1989-06-21 | 2- (5-Fluoronicotinoyl) -acetic acid derivatives and process for their preparation |
FI893074A FI85703C (en) | 1985-01-23 | 1989-06-22 | FOERFARANDE FOER FRAMSTAELLNING AV 1,4 -DIHYDRO-4-OXONAFTYRIDINDERIVAT. |
FI893075A FI87647C (en) | 1985-01-23 | 1989-06-22 | FAR OIL FRAMSTERING AV NYA 5-FLUORNICOTIN SYROR ELLER FOR CARBOXYL GROUP DETERMINING REACTIVE DERIVATIVES DAERAV ELLER SALTER DAERAV OCH DERAS MELLANPRODUKTER |
NO892693A NO167804C (en) | 1985-01-23 | 1989-06-28 | PROCEDURE FOR THE PREPARATION OF 1-SUBSTITUTED-PHENYL-1,4-DIHYDRO-4-OXONAFTYRIDINE DERIVATIVES. |
NO892692A NO174888C (en) | 1985-01-23 | 1989-06-28 | New 2- (5-fluoro-nicotinoyl) -acetic acid derivatives |
AT2003/89A AT392791B (en) | 1985-01-23 | 1989-08-24 | Process for the preparation of 1-substituted aryl-1,4- dihydro-4-oxonaphthyridine derivatives |
AT0200289A AT394193B (en) | 1985-01-23 | 1989-08-24 | Process for the preparation of novel 5-fluoronicotinic acids or derivatives and salts thereof |
DK285290A DK170532B1 (en) | 1985-01-23 | 1990-11-30 | 5-Fluornicotinic acid derivative or salt thereof or reactive derivative in the carboxyl group thereof |
DK285190A DK170857B1 (en) | 1985-01-23 | 1990-11-30 | 2- (5-Fluornicotinoyl) acetic acid derivative and process for its preparation |
NO924181A NO178574C (en) | 1985-01-23 | 1992-10-29 | New 5-fluoronicotinic acid derivatives |
NL9700011A NL193540C (en) | 1985-01-23 | 1997-11-06 | Method for preparing nicotinic acid derivatives. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP60028397A JPH0629246B2 (en) | 1985-02-18 | 1985-02-18 | 2- (5-fluoronicotinoyl) acetic acid derivative and its salt |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS61189269A true JPS61189269A (en) | 1986-08-22 |
JPH0629246B2 JPH0629246B2 (en) | 1994-04-20 |
Family
ID=12247527
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP60028397A Expired - Lifetime JPH0629246B2 (en) | 1985-01-23 | 1985-02-18 | 2- (5-fluoronicotinoyl) acetic acid derivative and its salt |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH0629246B2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0648990A (en) * | 1990-03-27 | 1994-02-22 | Pfizer Inc | Production of beta-ketoester useful for synthesizing quinolone antibiotic |
-
1985
- 1985-02-18 JP JP60028397A patent/JPH0629246B2/en not_active Expired - Lifetime
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0648990A (en) * | 1990-03-27 | 1994-02-22 | Pfizer Inc | Production of beta-ketoester useful for synthesizing quinolone antibiotic |
Also Published As
Publication number | Publication date |
---|---|
JPH0629246B2 (en) | 1994-04-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR880001078B1 (en) | Process for the preparation of 1-substituted arye-1,4-dihydro-4-oxonaphthyridine derivatives | |
ES2255733T3 (en) | SULFONYL DERIVATIVES. | |
JPS6320828B2 (en) | ||
EP0228845B1 (en) | N-containing heterocyclic compounds, processes for the preparation thereof and composition comprising the same | |
WO2015188787A1 (en) | Method for preparing oxazolidinone compound and intermediates thereof | |
US4851535A (en) | Nicotinic acid derivatives | |
JPS61189269A (en) | 2-(5-fluoronicotinoyl)acetic acid derivative and salt thereof | |
JPH0544949B2 (en) | ||
JPH0629247B2 (en) | 5-fluoronicotinic acid derivative and its salt | |
JP2000119253A (en) | Novel sulfonyl derivative | |
JPS61289088A (en) | Novel method for producing 1,4-dihydro-4-oxonaphtyridine derivative or salt thereof | |
JPS62181284A (en) | Novel cephalosporin compound and salt thereof | |
JPS61257985A (en) | Novel production of 1,4-dihydro-4-oxonaphthyridine derivative or salt thereof | |
CA1340648C (en) | Process for producing 1-substituted aryl-1, 4-dihydro-4-oxonaphthyridine derivative, intermediates therefor and porcesses for producing the intermediates | |
FI85703C (en) | FOERFARANDE FOER FRAMSTAELLNING AV 1,4 -DIHYDRO-4-OXONAFTYRIDINDERIVAT. | |
CA1340793C (en) | Process for producing 1-substituted aryl-1-4-dihydro-4-oxonaphthyridine derivative, intermediates therefor and processes for producing the intermediates | |
JPH0665671B2 (en) | Novel process for producing 1-substituted aryl-1,4-dihydro-4-oxonaphthyridine derivative or salt thereof | |
NO174888B (en) | New 2- (5-fluoro-nicotinoyl) -acetic acid derivatives | |
JPH0665670B2 (en) | 1,4-Dihydro-4-oxonaphthyridine derivatives and salts thereof | |
CH669378A5 (en) | 1-Fluoro:phenyl-1,8-naphthyridine-3-carboxylic acid derivs. prodn. | |
DE3641633C2 (en) | New 5-fluoronicotinic acid derivatives, their salts and reactive derivatives of the carboxyl group thereof | |
JPS62149661A (en) | 5-fluoronicotinic acid derivative and salt thereof | |
JPS6237006B2 (en) | ||
JPH0748351A (en) | New derivative of 5-fluoronicotinic acid compound reactive at carboxyl group | |
MXPA00003175A (en) | Sulfonyl derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EXPY | Cancellation because of completion of term |